Details of the Drug Combinations

General Information of This Drug (ID: DMH0ZJE)

Drug Name
Mitomycin   DMH0ZJE
Synonyms
Mitomycin C; mitomycin C; 1950/7/7; Mutamycin; Ametycine; Mitocin-C; Ametycin; Mitomycin-C; Mytozytrex; Mitomycinum; Mytomycin; Mitozytrex; Mitomycinum C; Mitocin C; Mitomycins; Mitamycin; MMC; Mitosol; Mitomycyna C; 7-Amino-9alpha-methoxymitosane; NSC-26980; Mitomycyna C [Polish]; Mito-C; Mit-C; Mitomycin (TN); Mitomycinum [INN-Latin]; Mitomycine [INN-French]; Mitomicina [INN-Spanish]; NCI-C04706; RCRA waste number U010; NSC26980; NSC 26980; Mitomycine; CCRIS 414; UNII-50SG953SK6; HSDB 3239; C15H18N4O5; EINECS 200-008-6; Mitomycin C,; Ametycin; Mitomicina; Muamycin; Mitomycin C from Streptomyces caespitosus; Mitomycin C (JP15); Mitomycin C, Streptomyces caespitosus; Muamycin (TN); Mitomycin (USP/INN); Mitomycin [USAN:INN:BAN]; Mitomycin C, Streptomyces caespitosus, Carrier-Free
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Approved [1]
Gastrointestinal cancer 2C11 Approved [1]
Pancreatic adenocarcinoma N.A. Approved [2]
Solid tumour/cancer 2A00-2F9Z Approved [3]
Urinary bladder cancer N.A. Approved [2]
Urinary bladder neoplasm N.A. Approved [2]
Urinary system neoplasm N.A. Approved [2]
Urinary tract disease GC2Z Approved [2]
Bladder disease DC11-DC1Z Investigative [2]
Colon cancer 2B90.Z Investigative [2]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1238 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
10-hydroxycamptothecin + Mitomycin DCTLWDD 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
10-hydroxycamptothecin + Mitomycin DCHT0WC 10-hydroxycamptothecin Chronic myelogenous leukemia (Cell Line: K-562) [4]
10-hydroxycamptothecin + Mitomycin DC9GTNX 10-hydroxycamptothecin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
10-hydroxycamptothecin + Mitomycin DC20EHL 10-hydroxycamptothecin Glioma (Cell Line: SF-295) [4]
10-hydroxycamptothecin + Mitomycin DCUPKVK 10-hydroxycamptothecin Glioma (Cell Line: SF-539) [4]
10-hydroxycamptothecin + Mitomycin DCN7A9H 10-hydroxycamptothecin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
10-hydroxycamptothecin + Mitomycin DCX5S03 10-hydroxycamptothecin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
10-hydroxycamptothecin + Mitomycin DCZR08E 10-hydroxycamptothecin Invasive ductal carcinoma (Cell Line: BT-549) [5]
10-hydroxycamptothecin + Mitomycin DCNMBK8 10-hydroxycamptothecin Adenocarcinoma (Cell Line: DU-145) [6]
10-hydroxycamptothecin + Mitomycin DCTN9C5 10-hydroxycamptothecin Adenocarcinoma (Cell Line: A549) [6]
10-hydroxycamptothecin + Mitomycin DCSLR0M 10-hydroxycamptothecin Adenocarcinoma (Cell Line: NCIH23) [6]
10-hydroxycamptothecin + Mitomycin DCETOPZ 10-hydroxycamptothecin Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
10-hydroxycamptothecin + Mitomycin DC43V2K 10-hydroxycamptothecin Large cell lung carcinoma (Cell Line: NCI-H460) [6]
10-hydroxycamptothecin + Mitomycin DC0Q86I 10-hydroxycamptothecin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
ABIRATERONE + Mitomycin DCN7QZN ABIRATERONE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
ABIRATERONE + Mitomycin DC801YA ABIRATERONE Clear cell renal cell carcinoma (Cell Line: A498) [4]
ABIRATERONE + Mitomycin DCW9X7V ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
ABIRATERONE + Mitomycin DCD8GFO ABIRATERONE Glioma (Cell Line: SF-268) [4]
ABIRATERONE + Mitomycin DCVH9MZ ABIRATERONE Plasma cell myeloma (Cell Line: RPMI-8226) [4]
ABIRATERONE + Mitomycin DC3L1PF ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [4]
ABIRATERONE + Mitomycin DCTVHMW ABIRATERONE Carcinoma (Cell Line: RXF 393) [5]
ABIRATERONE + Mitomycin DCFUHPD ABIRATERONE Carcinoma (Cell Line: MCF7) [5]
ABIRATERONE + Mitomycin DCGTECQ ABIRATERONE Invasive ductal carcinoma (Cell Line: BT-549) [5]
ABIRATERONE + Mitomycin DCYIHNX ABIRATERONE Adenocarcinoma (Cell Line: OVCAR3) [6]
ABIRATERONE + Mitomycin DCLZPEI ABIRATERONE Adenocarcinoma (Cell Line: HT29) [6]
ABIRATERONE + Mitomycin DC7DBKG ABIRATERONE Adenocarcinoma (Cell Line: SW-620) [6]
ABIRATERONE + Mitomycin DCODB33 ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
ABIRATERONE + Mitomycin DCOO3BK ABIRATERONE Lung adenocarcinoma (Cell Line: EKVX) [6]
ABIRATERONE + Mitomycin DCL4JVN ABIRATERONE Malignant melanoma (Cell Line: LOX IMVI) [6]
ABIRATERONE + Mitomycin DC6CX8Y ABIRATERONE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
ABT-263 + Mitomycin DC7FVA0 ABT-263 Diffuse large B cell lymphoma (Cell Line: TMD8) [6]
ABT-263 + Mitomycin DCIN0QA ABT-263 Ewing sarcoma (Cell Line: TC-71) [6]
AHPN + Mitomycin DCRAVTW AHPN Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Altretamine + Mitomycin DCREBQH Altretamine Adenocarcinoma (Cell Line: DU-145) [4]
Altretamine + Mitomycin DCJ841J Altretamine Adenocarcinoma (Cell Line: A549) [4]
Altretamine + Mitomycin DCFU2WL Altretamine Astrocytoma (Cell Line: SNB-19) [4]
Altretamine + Mitomycin DCPRV7D Altretamine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Altretamine + Mitomycin DCM67U0 Altretamine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Altretamine + Mitomycin DC5UENX Altretamine Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Altretamine + Mitomycin DCPRSGJ Altretamine Melanoma (Cell Line: SK-MEL-2) [4]
Altretamine + Mitomycin DCO5FUW Altretamine Melanoma (Cell Line: UACC-257) [4]
Altretamine + Mitomycin DCKBZIU Altretamine Renal cell carcinoma (Cell Line: SN12C) [4]
Altretamine + Mitomycin DC7KBGK Altretamine Carcinoma (Cell Line: MCF7) [5]
Altretamine + Mitomycin DCCO0E6 Altretamine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Aminolevulinic Acid Hydrochloride + Mitomycin DCI7VGK Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [4]
Aminolevulinic Acid Hydrochloride + Mitomycin DCFCZI3 Aminolevulinic Acid Hydrochloride Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Amonafide + Mitomycin DCL29FR Amonafide Adenocarcinoma (Cell Line: OVCAR3) [4]
Amonafide + Mitomycin DCRMTHT Amonafide Adenocarcinoma (Cell Line: NCIH23) [4]
Amonafide + Mitomycin DCM7X2S Amonafide Adenocarcinoma (Cell Line: HCT-15) [4]
Amonafide + Mitomycin DC2NR25 Amonafide Adenocarcinoma (Cell Line: HCT116) [4]
Amonafide + Mitomycin DC3SET9 Amonafide Adenocarcinoma (Cell Line: HT29) [4]
Amonafide + Mitomycin DCA0LIX Amonafide Adenocarcinoma (Cell Line: SW-620) [4]
Amonafide + Mitomycin DCIG1NZ Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Amonafide + Mitomycin DCVZJF9 Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Amonafide + Mitomycin DCSM3GE Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [4]
Amonafide + Mitomycin DCE71ML Amonafide Astrocytoma (Cell Line: U251) [4]
Amonafide + Mitomycin DCFWKTU Amonafide Astrocytoma (Cell Line: SNB-19) [4]
Amonafide + Mitomycin DC3C4QQ Amonafide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Amonafide + Mitomycin DCYTEHO Amonafide Chronic myelogenous leukemia (Cell Line: K-562) [4]
Amonafide + Mitomycin DC519TC Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Amonafide + Mitomycin DC3I6CC Amonafide Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Amonafide + Mitomycin DC524M3 Amonafide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Amonafide + Mitomycin DCDOOBH Amonafide Glioblastoma (Cell Line: SNB-75) [4]
Amonafide + Mitomycin DCHCHYJ Amonafide Glioma (Cell Line: SF-268) [4]
Amonafide + Mitomycin DCWIWGQ Amonafide Lung adenocarcinoma (Cell Line: EKVX) [4]
Amonafide + Mitomycin DCSRGZM Amonafide Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Amonafide + Mitomycin DCV0F7I Amonafide Melanoma (Cell Line: MALME-3M) [4]
Amonafide + Mitomycin DCCU0X9 Amonafide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Amonafide + Mitomycin DCA9O4T Amonafide Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Amonafide + Mitomycin DC0NYOH Amonafide Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Amonafide + Mitomycin DC5NFX7 Amonafide Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Amonafide + Mitomycin DCGVBCW Amonafide Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Amonafide + Mitomycin DCUTNSP Amonafide Renal cell carcinoma (Cell Line: SN12C) [4]
Amonafide + Mitomycin DCXIB87 Amonafide Carcinoma (Cell Line: RXF 393) [5]
Amonafide + Mitomycin DCCMOW0 Amonafide Carcinoma (Cell Line: MCF7) [5]
Amonafide + Mitomycin DCIOYZD Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [5]
Amonafide + Mitomycin DCO3TZV Amonafide Invasive ductal carcinoma (Cell Line: BT-549) [5]
Amonafide + Mitomycin DCG34F7 Amonafide Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Mitomycin DCWH7HC Anastrozole Adenocarcinoma (Cell Line: HCT-15) [4]
Anastrozole + Mitomycin DCBXJI6 Anastrozole Adenocarcinoma (Cell Line: HCT116) [4]
Anastrozole + Mitomycin DCCKGCE Anastrozole Adenocarcinoma (Cell Line: HT29) [4]
Anastrozole + Mitomycin DCZEDZQ Anastrozole Adenocarcinoma (Cell Line: SW-620) [4]
Anastrozole + Mitomycin DCXSS5T Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Anastrozole + Mitomycin DC0VBWO Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [4]
Anastrozole + Mitomycin DCN8360 Anastrozole Astrocytoma (Cell Line: U251) [4]
Anastrozole + Mitomycin DC0TS3E Anastrozole Astrocytoma (Cell Line: SNB-19) [4]
Anastrozole + Mitomycin DCP9RQP Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Anastrozole + Mitomycin DC44FGN Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [4]
Anastrozole + Mitomycin DCYW5BE Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Anastrozole + Mitomycin DCKD7HB Anastrozole Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Anastrozole + Mitomycin DC3B7IK Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Anastrozole + Mitomycin DC1TYS6 Anastrozole Lung adenocarcinoma (Cell Line: HOP-62) [4]
Anastrozole + Mitomycin DC4ZJTA Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Anastrozole + Mitomycin DCN22JQ Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [4]
Anastrozole + Mitomycin DCW17C4 Anastrozole Melanoma (Cell Line: MALME-3M) [4]
Anastrozole + Mitomycin DCX8WH2 Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Anastrozole + Mitomycin DCW3P9Z Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Anastrozole + Mitomycin DCMJT67 Anastrozole Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Anastrozole + Mitomycin DC8OCUC Anastrozole Prostate carcinoma (Cell Line: PC-3) [4]
Anastrozole + Mitomycin DC0EIYD Anastrozole Renal cell carcinoma (Cell Line: UO-31) [4]
Anastrozole + Mitomycin DCG086K Anastrozole Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Mitomycin DCG8NEH Anastrozole Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Mitomycin DCTLEKO Anastrozole Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Mitomycin DCEZDER Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Mitomycin DCKBAXG Anastrozole Invasive ductal carcinoma (Cell Line: BT-549) [5]
AR-42 + Mitomycin DCYS4K2 AR-42 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Arfolitixorin + Mitomycin DCYODNY Arfolitixorin Astrocytoma (Cell Line: U251) [4]
Arfolitixorin + Mitomycin DCL4UT1 Arfolitixorin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Arfolitixorin + Mitomycin DCTOIPO Arfolitixorin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Arfolitixorin + Mitomycin DCSSYX2 Arfolitixorin Glioma (Cell Line: SF-268) [4]
Arfolitixorin + Mitomycin DCRVOMS Arfolitixorin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Arfolitixorin + Mitomycin DCCHWZ7 Arfolitixorin Carcinoma (Cell Line: MCF7) [5]
Arfolitixorin + Mitomycin DCBW0FH Arfolitixorin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Arfolitixorin + Mitomycin DCS5ZJH Arfolitixorin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Arfolitixorin + Mitomycin DC9KAIA Arfolitixorin Adenocarcinoma (Cell Line: SW-620) [6]
Arfolitixorin + Mitomycin DCOEOYA Arfolitixorin Adenocarcinoma (Cell Line: HT29) [6]
Arfolitixorin + Mitomycin DCHF99G Arfolitixorin Adenocarcinoma (Cell Line: HCT116) [6]
AS602868 + Mitomycin DCZXMEI AS602868 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
AT7519 + Mitomycin DCBE0UD AT7519 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Azacitidine + Mitomycin DC8KAZM Azacitidine Adenocarcinoma (Cell Line: DU-145) [4]
Azacitidine + Mitomycin DCJ80N2 Azacitidine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Azacitidine + Mitomycin DCR7UTO Azacitidine Anaplastic large cell lymphoma (Cell Line: SR) [4]
Azacitidine + Mitomycin DCPC74T Azacitidine Astrocytoma (Cell Line: U251) [4]
Azacitidine + Mitomycin DCCJRMM Azacitidine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Azacitidine + Mitomycin DCOZHQR Azacitidine Chronic myelogenous leukemia (Cell Line: K-562) [4]
Azacitidine + Mitomycin DCA8V5I Azacitidine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Azacitidine + Mitomycin DC1FRY6 Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Azacitidine + Mitomycin DCMH0UC Azacitidine Malignant melanoma (Cell Line: UACC62) [4]
Azacitidine + Mitomycin DCC9WWK Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Azacitidine + Mitomycin DC2VG9L Azacitidine Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Azacitidine + Mitomycin DCA90KE Azacitidine Invasive ductal carcinoma (Cell Line: BT-549) [5]
AZD6482 + Mitomycin DCICP43 AZD6482 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
AZD7762 + Mitomycin DCT3C7W AZD7762 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
BAG956 + Mitomycin DCCKRSI BAG956 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Bardoxolone methyl + Mitomycin DCQVDPS Bardoxolone methyl Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Belinostat + Mitomycin DCCN4LC Belinostat Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
BIO-300 + Mitomycin DC5MFT0 BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
BIO-300 + Mitomycin DCDQZN1 BIO-300 Astrocytoma (Cell Line: SNB-19) [4]
BIO-300 + Mitomycin DC6WZ6L BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
BIO-300 + Mitomycin DC8BJIW BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [4]
BIO-300 + Mitomycin DCUVHGO BIO-300 Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
BIO-300 + Mitomycin DCG4VK0 BIO-300 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
BIO-300 + Mitomycin DCK6HFM BIO-300 Glioblastoma (Cell Line: SNB-75) [4]
BIO-300 + Mitomycin DCJC30S BIO-300 Glioma (Cell Line: SF-539) [4]
BIO-300 + Mitomycin DCTFWP4 BIO-300 Glioma (Cell Line: SF-268) [4]
BIO-300 + Mitomycin DCDXFGY BIO-300 Glioma (Cell Line: SF-295) [4]
BIO-300 + Mitomycin DCZQ0AZ BIO-300 Papillary renal cell carcinoma (Cell Line: ACHN) [4]
BIO-300 + Mitomycin DCAVQVN BIO-300 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
BIO-300 + Mitomycin DCHGMVY BIO-300 Carcinoma (Cell Line: MCF7) [5]
BIO-300 + Mitomycin DC2H6RF BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [5]
BIO-300 + Mitomycin DCKF2UC BIO-300 Invasive ductal carcinoma (Cell Line: T-47D) [5]
BIO-300 + Mitomycin DCVUWZR BIO-300 Invasive ductal carcinoma (Cell Line: BT-549) [5]
BIO-300 + Mitomycin DCQ0G4R BIO-300 Adenocarcinoma (Cell Line: OVCAR3) [6]
BIO-300 + Mitomycin DC8UW9E BIO-300 Adenocarcinoma (Cell Line: NCIH23) [6]
BIO-300 + Mitomycin DC99OM9 BIO-300 Adenocarcinoma (Cell Line: SW-620) [6]
BIO-300 + Mitomycin DCUMBOY BIO-300 Adenocarcinoma (Cell Line: HCT-15) [6]
BIO-300 + Mitomycin DC8UR2A BIO-300 Adenocarcinoma (Cell Line: HCT116) [6]
BIO-300 + Mitomycin DCBS2XT BIO-300 Adenocarcinoma (Cell Line: HT29) [6]
BIO-300 + Mitomycin DCSYNTH BIO-300 Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
BIO-300 + Mitomycin DCXFEUU BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
BIO-300 + Mitomycin DC60XUB BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
BIO-300 + Mitomycin DCJEZ1L BIO-300 Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
BIO-300 + Mitomycin DCV2GF9 BIO-300 Lung adenocarcinoma (Cell Line: EKVX) [6]
BIO-300 + Mitomycin DC1PGU8 BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
BIO-300 + Mitomycin DCO4IBL BIO-300 Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
BIO-300 + Mitomycin DCW5TCI BIO-300 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Bleomycin + Mitomycin DCCT645 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Bleomycin + Mitomycin DCANU2R Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Bleomycin + Mitomycin DCQZSLX Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [4]
Bleomycin + Mitomycin DCWYRQA Bleomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Bleomycin + Mitomycin DCAHJDN Bleomycin Glioma (Cell Line: SF-295) [4]
Bleomycin + Mitomycin DCI41LS Bleomycin Glioma (Cell Line: SF-268) [4]
Bleomycin + Mitomycin DCU1C2A Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Bleomycin + Mitomycin DCR6BEH Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Bleomycin + Mitomycin DCN9CI2 Bleomycin Carcinoma (Cell Line: RXF 393) [5]
Bleomycin + Mitomycin DCUU4OV Bleomycin Carcinoma (Cell Line: MCF7) [5]
Bleomycin + Mitomycin DCPLYNB Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Bleomycin + Mitomycin DC1GFS0 Bleomycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Bleomycin + Mitomycin DCA5BUO Bleomycin Adenocarcinoma (Cell Line: HCT-15) [6]
Bleomycin + Mitomycin DC42J2M Bleomycin Adenocarcinoma (Cell Line: HCT116) [6]
Bleomycin + Mitomycin DCCGTPE Bleomycin Adenocarcinoma (Cell Line: SW-620) [6]
Bleomycin + Mitomycin DCADZIL Bleomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
BMS-509744 + Mitomycin DC7AF98 BMS-509744 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Bortezomib + Mitomycin DC7F94O Bortezomib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Busulfan + Mitomycin DC98WOL Busulfan Adenocarcinoma (Cell Line: DU-145) [4]
Busulfan + Mitomycin DCIV84Z Busulfan Adenocarcinoma (Cell Line: HT29) [4]
Busulfan + Mitomycin DCX6UT2 Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Busulfan + Mitomycin DCXXTI4 Busulfan Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Busulfan + Mitomycin DC3XOYD Busulfan Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Busulfan + Mitomycin DCWXCL6 Busulfan Plasma cell myeloma (Cell Line: RPMI-8226) [4]
BX-795 + Mitomycin DCO1VK7 BX-795 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
CA4P + Mitomycin DCSUFVV CA4P Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Cabazitaxel + Mitomycin DCT2D84 Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [4]
Cabazitaxel + Mitomycin DCF4NFI Cabazitaxel Astrocytoma (Cell Line: SNB-19) [4]
Cabazitaxel + Mitomycin DCSCYO7 Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Cabazitaxel + Mitomycin DCS00R7 Cabazitaxel Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Cabazitaxel + Mitomycin DCZLWF6 Cabazitaxel Glioblastoma (Cell Line: SNB-75) [4]
Cabazitaxel + Mitomycin DCHJQGN Cabazitaxel Glioma (Cell Line: SF-268) [4]
Cabazitaxel + Mitomycin DC1S6LQ Cabazitaxel Glioma (Cell Line: SF-295) [4]
Cabazitaxel + Mitomycin DC7YPMU Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Cabazitaxel + Mitomycin DC1GOC3 Cabazitaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Cabazitaxel + Mitomycin DCC6ACS Cabazitaxel Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Cabazitaxel + Mitomycin DC0Z46Q Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Carfilzomib + Mitomycin DCNV0G0 Carfilzomib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
CITCO + Mitomycin DCX4H11 CITCO Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Crizotinib + Mitomycin DCZR22K Crizotinib Adenocarcinoma (Cell Line: SW-620) [4]
Crizotinib + Mitomycin DCK75OP Crizotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Crizotinib + Mitomycin DC8MJP2 Crizotinib Astrocytoma (Cell Line: SNB-19) [4]
Crizotinib + Mitomycin DCHHZZ1 Crizotinib Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Crizotinib + Mitomycin DCOJHC4 Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Crizotinib + Mitomycin DC8NSZB Crizotinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Crizotinib + Mitomycin DC0KBDX Crizotinib Glioblastoma (Cell Line: SNB-75) [4]
Crizotinib + Mitomycin DCXDJFT Crizotinib Glioma (Cell Line: SF-268) [4]
Crizotinib + Mitomycin DCVIY00 Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Crizotinib + Mitomycin DCT9KT5 Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [4]
Crizotinib + Mitomycin DCQ5A0M Crizotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Crizotinib + Mitomycin DCVRCEL Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Crizotinib + Mitomycin DCKX38X Crizotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Crizotinib + Mitomycin DC0TRBA Crizotinib Carcinoma (Cell Line: RXF 393) [5]
Crizotinib + Mitomycin DCWS2KT Crizotinib Carcinoma (Cell Line: MCF7) [5]
Crizotinib + Mitomycin DC2ZPBJ Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Crizotinib + Mitomycin DC312QD Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
CUDC-101 + Mitomycin DCLLSV2 CUDC-101 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Cyclophosphamide + Mitomycin DCTJLJN Cyclophosphamide Adenocarcinoma (Cell Line: DU-145) [4]
Cyclophosphamide + Mitomycin DC8MYKM Cyclophosphamide Adenocarcinoma (Cell Line: HCT-15) [4]
Cyclophosphamide + Mitomycin DCA1AUG Cyclophosphamide Adenocarcinoma (Cell Line: HT29) [4]
Cyclophosphamide + Mitomycin DCEM8KN Cyclophosphamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Cyclophosphamide + Mitomycin DC0HWYR Cyclophosphamide Astrocytoma (Cell Line: SNB-19) [4]
Cyclophosphamide + Mitomycin DC562JO Cyclophosphamide Glioma (Cell Line: SF-268) [4]
Cyclophosphamide + Mitomycin DCZH66Q Cyclophosphamide Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Cyclophosphamide + Mitomycin DCZ3C7P Cyclophosphamide Lung adenocarcinoma (Cell Line: HOP-62) [4]
Cyclophosphamide + Mitomycin DCBF60V Cyclophosphamide Melanoma (Cell Line: SK-MEL-2) [4]
Cyclophosphamide + Mitomycin DC7FFR6 Cyclophosphamide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Cyclophosphamide + Mitomycin DCDK21F Cyclophosphamide Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dacarbazine + Mitomycin DCI9L71 Dacarbazine Adenocarcinoma (Cell Line: SW-620) [4]
Dacarbazine + Mitomycin DCJAUA1 Dacarbazine Adenocarcinoma (Cell Line: HT29) [4]
Dacarbazine + Mitomycin DCFRPVD Dacarbazine Adenocarcinoma (Cell Line: HCT-15) [4]
Dacarbazine + Mitomycin DC7XC34 Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Dacarbazine + Mitomycin DCCMPVQ Dacarbazine Glioma (Cell Line: SF-268) [4]
Dacarbazine + Mitomycin DCP0N3Y Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Dacarbazine + Mitomycin DC619GZ Dacarbazine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Dacarbazine + Mitomycin DCSKSF5 Dacarbazine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Dacarbazine + Mitomycin DCNLR2P Dacarbazine Carcinoma (Cell Line: RXF 393) [5]
Dacarbazine + Mitomycin DCF6GX5 Dacarbazine Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dacarbazine + Mitomycin DC8UJDC Dacarbazine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Dactinomycin + Mitomycin DCD1VJT Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Dactinomycin + Mitomycin DCQGN4V Dactinomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dactinomycin + Mitomycin DCQTNPG Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [6]
Dactinomycin + Mitomycin DC9F96B Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [6]
Dactinomycin + Mitomycin DC1QPWS Dactinomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Dasatinib + Mitomycin DCTLEOJ Dasatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Dasatinib + Mitomycin DCDXJHZ Dasatinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Dasatinib + Mitomycin DCJIONV Dasatinib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Dasatinib + Mitomycin DCW1CA0 Dasatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Deguelin + Mitomycin DC5Y0AN Deguelin Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Dexamethasone + Mitomycin DCD221N Dexamethasone Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Dexrazoxane + Mitomycin DC7WXOS Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Dexrazoxane + Mitomycin DCXUJ1P Dexrazoxane Glioma (Cell Line: SF-268) [4]
Dexrazoxane + Mitomycin DCE4OD3 Dexrazoxane Carcinoma (Cell Line: RXF 393) [5]
Dexrazoxane + Mitomycin DCGDMHM Dexrazoxane Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Dexrazoxane + Mitomycin DCA0GEN Dexrazoxane Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Mitomycin DCDB3LN Dexrazoxane Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Mitomycin DCUSVS8 Dexrazoxane Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
DFN-15 + Mitomycin DCYDGNT DFN-15 Colon carcinoma (Cell Line: KM12) [5]
DFN-15 + Mitomycin DCJ67LR DFN-15 Adenocarcinoma (Cell Line: HCT-15) [6]
Digitoxin + Mitomycin DCNURVI Digitoxin Adenocarcinoma (Cell Line: A549) [4]
Digitoxin + Mitomycin DC36ZPL Digitoxin Adenocarcinoma (Cell Line: HCT116) [4]
Digitoxin + Mitomycin DCLKPHW Digitoxin Adenocarcinoma (Cell Line: HCT-15) [4]
Digitoxin + Mitomycin DCDXBBU Digitoxin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Digitoxin + Mitomycin DC5OIND Digitoxin Anaplastic large cell lymphoma (Cell Line: SR) [4]
Digitoxin + Mitomycin DCS4N8D Digitoxin Astrocytoma (Cell Line: SNB-19) [4]
Digitoxin + Mitomycin DCQEHHH Digitoxin Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Digitoxin + Mitomycin DCVVOYG Digitoxin Glioma (Cell Line: SF-539) [4]
Digitoxin + Mitomycin DCM3OWN Digitoxin Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Digitoxin + Mitomycin DCNWFNJ Digitoxin Malignant melanoma (Cell Line: UACC62) [4]
Digitoxin + Mitomycin DCKA68P Digitoxin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Digitoxin + Mitomycin DCZTPVR Digitoxin Invasive ductal carcinoma (Cell Line: T-47D) [5]
Docetaxel + Mitomycin DC0VNZF Docetaxel Adenocarcinoma (Cell Line: DU-145) [4]
Docetaxel + Mitomycin DCBHTL3 Docetaxel Adenocarcinoma (Cell Line: HCT116) [4]
Docetaxel + Mitomycin DCHDXCB Docetaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Docetaxel + Mitomycin DCW1QOU Docetaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Docetaxel + Mitomycin DC51LF1 Docetaxel Astrocytoma (Cell Line: SNB-19) [4]
Docetaxel + Mitomycin DCVK52L Docetaxel Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Docetaxel + Mitomycin DCMRKFC Docetaxel Glioma (Cell Line: SF-539) [4]
Docetaxel + Mitomycin DCVBOCT Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Docetaxel + Mitomycin DC8H4XB Docetaxel Colon adenocarcinoma (Cell Line: COLO 205) [5]
Doxorubicin + Mitomycin DCAFB4N Doxorubicin Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Elesclomol + Mitomycin DCS38EK Elesclomol Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Epirubicin + Mitomycin DC6L1AF Epirubicin Astrocytoma (Cell Line: SNB-19) [4]
Epirubicin + Mitomycin DCP4CF9 Epirubicin Renal cell carcinoma (Cell Line: UO-31) [4]
Epirubicin + Mitomycin DCQERBC Epirubicin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Epirubicin + Mitomycin DC9WQ4R Epirubicin Carcinoma (Cell Line: RXF 393) [5]
Epirubicin + Mitomycin DC2ODP5 Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Epirubicin + Mitomycin DCSBEIK Epirubicin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Epirubicin + Mitomycin DCAB0ST Epirubicin Adenocarcinoma (Cell Line: OVCAR3) [6]
Epirubicin + Mitomycin DCH59H8 Epirubicin Adenocarcinoma (Cell Line: HCT-15) [6]
Epirubicin + Mitomycin DCQ8OVP Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Epirubicin + Mitomycin DCIMYU7 Epirubicin Lung adenocarcinoma (Cell Line: EKVX) [6]
Epirubicin + Mitomycin DCEZON7 Epirubicin Malignant melanoma (Cell Line: LOX IMVI) [6]
Epirubicin + Mitomycin DCA6TRX Epirubicin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Estramustine + Mitomycin DCFX6C6 Estramustine Chronic myelogenous leukemia (Cell Line: K-562) [4]
Estramustine + Mitomycin DCK0YS1 Estramustine Glioma (Cell Line: SF-268) [4]
Estramustine + Mitomycin DC97WX0 Estramustine Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Estramustine + Mitomycin DCL1XI7 Estramustine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Estramustine + Mitomycin DCUJ2DR Estramustine Adenocarcinoma (Cell Line: HCC-2998) [6]
Estramustine + Mitomycin DCVM7UZ Estramustine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Estramustine + Mitomycin DC87JSR Estramustine Lung adenocarcinoma (Cell Line: HOP-62) [6]
Everolimus + Mitomycin DCVEFHK Everolimus Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Everolimus + Mitomycin DCI2GB9 Everolimus Ewing sarcoma (Cell Line: TC-71) [4]
Exherin + Mitomycin DCB4AIB Exherin Ewing sarcoma (Cell Line: TC-71) [4]
Flavopiridol + Mitomycin DCO79WP Flavopiridol Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Fludarabine + Mitomycin DCCLT26 Fludarabine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Fludarabine + Mitomycin DCMB52W Fludarabine Glioma (Cell Line: SF-539) [4]
Fludarabine + Mitomycin DCDCYZQ Fludarabine Adenocarcinoma (Cell Line: HCT-15) [6]
Fluorouracil + Mitomycin DCEPLSW Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Fluorouracil + Mitomycin DCFECAP Fluorouracil Breast carcinoma (Cell Line: KPL1) [5]
Fluorouracil + Mitomycin DCDVDSK Fluorouracil Breast carcinoma (Cell Line: OCUBM) [5]
Fluorouracil + Mitomycin DCN7R2N Fluorouracil Colon adenocarcinoma (Cell Line: LOVO) [5]
Fluorouracil + Mitomycin DCVOTYU Fluorouracil Colon carcinoma (Cell Line: RKO) [5]
Fluorouracil + Mitomycin DCWEHB8 Fluorouracil Invasive ductal carcinoma (Cell Line: T-47D) [5]
Fluorouracil + Mitomycin DC2LV6T Fluorouracil Adenocarcinoma (Cell Line: CAOV3) [6]
Fluorouracil + Mitomycin DCX6QYU Fluorouracil Adenocarcinoma (Cell Line: A427) [6]
Fluorouracil + Mitomycin DCEJJ9K Fluorouracil Adenocarcinoma (Cell Line: NCIH23) [6]
Fluorouracil + Mitomycin DCVIZPG Fluorouracil Adenocarcinoma (Cell Line: COLO320DM) [6]
Fluorouracil + Mitomycin DCKN7CW Fluorouracil Adenocarcinoma (Cell Line: HT29) [6]
Fluorouracil + Mitomycin DCQEREL Fluorouracil Germ cell tumour (Cell Line: PA1) [6]
Fluorouracil + Mitomycin DCHY7NU Fluorouracil Malignant melanoma (Cell Line: A375) [6]
Fluorouracil + Mitomycin DCKRLLF Fluorouracil Malignant melanoma (Cell Line: SKMEL30) [6]
Fluorouracil + Mitomycin DC55XED Fluorouracil Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
FORMESTANE + Mitomycin DC3FKPK FORMESTANE Adenocarcinoma (Cell Line: HCC-2998) [4]
FORMESTANE + Mitomycin DCU4MNN FORMESTANE Adenocarcinoma (Cell Line: HCT-15) [4]
FORMESTANE + Mitomycin DC4PTSU FORMESTANE Glioma (Cell Line: SF-295) [4]
FORMESTANE + Mitomycin DCWMQWG FORMESTANE High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
FORMESTANE + Mitomycin DCTUDFZ FORMESTANE Lung adenocarcinoma (Cell Line: HOP-62) [4]
FORMESTANE + Mitomycin DCSC5LK FORMESTANE Melanoma (Cell Line: MALME-3M) [4]
Fulvestrant + Mitomycin DCSPOPV Fulvestrant Melanoma (Cell Line: MALME-3M) [4]
Fulvestrant + Mitomycin DCJZG0L Fulvestrant Renal cell carcinoma (Cell Line: UO-31) [4]
Gefitinib + Mitomycin DCAGBD3 Gefitinib Adenocarcinoma (Cell Line: SW-620) [4]
Gefitinib + Mitomycin DCIDF9C Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [4]
Gefitinib + Mitomycin DCK65BG Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Gefitinib + Mitomycin DCM3550 Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [4]
Gefitinib + Mitomycin DCUEVH5 Gefitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Gefitinib + Mitomycin DCQEJUP Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Gefitinib + Mitomycin DCZATA3 Gefitinib Glioma (Cell Line: SF-268) [4]
Gefitinib + Mitomycin DCKBPEM Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Gefitinib + Mitomycin DC37BOK Gefitinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Gefitinib + Mitomycin DCTMDD2 Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [4]
Gefitinib + Mitomycin DC45TPD Gefitinib Melanoma (Cell Line: MALME-3M) [4]
Gefitinib + Mitomycin DC7HJX4 Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Gefitinib + Mitomycin DC9DGEC Gefitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Gefitinib + Mitomycin DCMG1AY Gefitinib Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Gefitinib + Mitomycin DC2E9V2 Gefitinib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Gefitinib + Mitomycin DC491NZ Gefitinib Renal cell carcinoma (Cell Line: SN12C) [4]
Gefitinib + Mitomycin DCJIAFS Gefitinib Carcinoma (Cell Line: RXF 393) [5]
Gefitinib + Mitomycin DCYQ68A Gefitinib Carcinoma (Cell Line: MCF7) [5]
Gefitinib + Mitomycin DCKVXLO Gefitinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Gefitinib + Mitomycin DC7C1O3 Gefitinib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
GSK461364 + Mitomycin DC5ACO5 GSK461364 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
GSK690693 + Mitomycin DC5MIFB GSK690693 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
GYKI-53655 + Mitomycin DCM3FFN GYKI-53655 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Hepzato + Mitomycin DCG2Y7J Hepzato Renal cell carcinoma (Cell Line: UO-31) [4]
Hepzato + Mitomycin DCYH9NP Hepzato High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Hepzato + Mitomycin DCIY4S1 Hepzato Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
IC87114 + Mitomycin DCYRB1K IC87114 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Idarubicin + Mitomycin DCXXANH Idarubicin Clear cell renal cell carcinoma (Cell Line: A498) [4]
Idarubicin + Mitomycin DCXQ3WG Idarubicin Renal cell carcinoma (Cell Line: SN12C) [4]
Idarubicin + Mitomycin DCQP2X6 Idarubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Idarubicin + Mitomycin DCDA8HP Idarubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Idelalisib + Mitomycin DCL5A6G Idelalisib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Imatinib + Mitomycin DC266VA Imatinib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Imatinib + Mitomycin DCF0GDQ Imatinib Lung adenocarcinoma (Cell Line: EKVX) [4]
Imatinib + Mitomycin DC556D3 Imatinib Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Imatinib + Mitomycin DCBJA9T Imatinib Colon carcinoma (Cell Line: KM12) [5]
Indazole derivative 5 + Mitomycin DC3Z56V Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Indazole derivative 5 + Mitomycin DC5844F Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [4]
Indazole derivative 5 + Mitomycin DC7934S Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Indazole derivative 5 + Mitomycin DCF6APB Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Indazole derivative 5 + Mitomycin DCPD3PV Indazole derivative 5 Glioma (Cell Line: SF-268) [4]
Indazole derivative 5 + Mitomycin DCHOQJS Indazole derivative 5 Carcinoma (Cell Line: RXF 393) [5]
Indazole derivative 5 + Mitomycin DCBWL3U Indazole derivative 5 Colon carcinoma (Cell Line: KM12) [5]
Indazole derivative 5 + Mitomycin DCFWBRY Indazole derivative 5 Invasive ductal carcinoma (Cell Line: BT-549) [5]
Indazole derivative 5 + Mitomycin DCIYWZX Indazole derivative 5 Adenocarcinoma (Cell Line: HT29) [6]
Indazole derivative 5 + Mitomycin DC8FKX1 Indazole derivative 5 Adenocarcinoma (Cell Line: SW-620) [6]
Indazole derivative 5 + Mitomycin DC0HPV2 Indazole derivative 5 Lung adenocarcinoma (Cell Line: EKVX) [6]
Indazole derivative 5 + Mitomycin DCMQDHF Indazole derivative 5 Malignant melanoma (Cell Line: UACC62) [6]
Indazole derivative 5 + Mitomycin DCMVAXI Indazole derivative 5 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Indazole derivative 5 + Mitomycin DCRMB15 Indazole derivative 5 Prostate carcinoma (Cell Line: PC-3) [6]
Isoniazid + Mitomycin DC9P6GP Isoniazid Anaplastic large cell lymphoma (Cell Line: SR) [4]
Isoniazid + Mitomycin DCWBM3J Isoniazid Astrocytoma (Cell Line: SNB-19) [4]
Isoniazid + Mitomycin DC6WMKF Isoniazid Melanoma (Cell Line: SK-MEL-2) [4]
Ispinesib + Mitomycin DCEIPSM Ispinesib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
JNJ-26854165 + Mitomycin DCM9V2C JNJ-26854165 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
JNK-IN-8 + Mitomycin DCSGTR8 JNK-IN-8 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
JNK-IN-8 + Mitomycin DCN779B JNK-IN-8 Glioma (Cell Line: SF-268) [4]
JNK-IN-8 + Mitomycin DCR145Y JNK-IN-8 Colon adenocarcinoma (Cell Line: COLO 205) [5]
JNK-IN-8 + Mitomycin DCP7DFI JNK-IN-8 Invasive ductal carcinoma (Cell Line: HS 578T) [5]
JNK-IN-8 + Mitomycin DC11U4I JNK-IN-8 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
JNK-IN-8 + Mitomycin DCQ8XVZ JNK-IN-8 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
JQ1 + Mitomycin DC6SOCF JQ1 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
KU-0060648 + Mitomycin DC0PO9X KU-0060648 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Lapatinib + Mitomycin DCZAGR9 Lapatinib Adenocarcinoma (Cell Line: DU-145) [6]
Lapatinib + Mitomycin DC4D3WM Lapatinib Adenocarcinoma (Cell Line: A549) [6]
Lapatinib + Mitomycin DCUYSK5 Lapatinib Adenocarcinoma (Cell Line: HCC-2998) [6]
Lapatinib + Mitomycin DC1MNCT Lapatinib Adenocarcinoma (Cell Line: HCT116) [6]
Lapatinib + Mitomycin DC66HYP Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Lapatinib + Mitomycin DC3U84V Lapatinib Melanoma (Cell Line: MALME-3M) [6]
Lapatinib + Mitomycin DC50YMI Lapatinib Renal cell carcinoma (Cell Line: UO-31) [6]
Lenalidomide + Mitomycin DCXD5SN Lenalidomide Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Lenalidomide + Mitomycin DCTY04F Lenalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Lenalidomide + Mitomycin DC0LSLF Lenalidomide Carcinoma (Cell Line: RXF 393) [5]
Lenalidomide + Mitomycin DC3C7D9 Lenalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Lenalidomide + Mitomycin DCIRBI5 Lenalidomide Invasive ductal carcinoma (Cell Line: BT-549) [5]
Lenalidomide + Mitomycin DCBF2RY Lenalidomide Adenocarcinoma (Cell Line: NCIH23) [6]
Lenalidomide + Mitomycin DC2OZF3 Lenalidomide Adenocarcinoma (Cell Line: HT29) [6]
Lenalidomide + Mitomycin DCO126F Lenalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Lenalidomide + Mitomycin DCXSB7H Lenalidomide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Lestaurtinib + Mitomycin DC2T0WD Lestaurtinib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Letrozole + Mitomycin DC9SZT1 Letrozole Adenocarcinoma (Cell Line: HCC-2998) [4]
Letrozole + Mitomycin DCM0Y0R Letrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Letrozole + Mitomycin DCKAK9A Letrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Letrozole + Mitomycin DC5TA9C Letrozole Plasma cell myeloma (Cell Line: RPMI-8226) [4]
LIAROZOLE + Mitomycin DC9BNWV LIAROZOLE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
LIAROZOLE + Mitomycin DCC94WR LIAROZOLE Glioma (Cell Line: SF-539) [4]
LIAROZOLE + Mitomycin DCMGBDO LIAROZOLE Adenocarcinoma (Cell Line: HCT116) [6]
LIAROZOLE + Mitomycin DCBA0FE LIAROZOLE Adenocarcinoma (Cell Line: HCT-15) [6]
LY333531 + Mitomycin DCHIZVV LY333531 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Mechlorethamine + Mitomycin DCA2P3L Mechlorethamine Anaplastic large cell lymphoma (Cell Line: SR) [4]
Mechlorethamine + Mitomycin DCH3XCH Mechlorethamine Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Mechlorethamine + Mitomycin DCL6Y1W Mechlorethamine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Mechlorethamine + Mitomycin DCFOFEJ Mechlorethamine Carcinoma (Cell Line: RXF 393) [5]
Mechlorethamine + Mitomycin DCGXOAF Mechlorethamine Colon adenocarcinoma (Cell Line: COLO 205) [5]
Mechlorethamine + Mitomycin DCAYDYU Mechlorethamine Colon carcinoma (Cell Line: KM12) [5]
Mechlorethamine + Mitomycin DCBSYKM Mechlorethamine Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Mechlorethamine + Mitomycin DCIRXY8 Mechlorethamine Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Mechlorethamine + Mitomycin DCZ2EZN Mechlorethamine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Mechlorethamine + Mitomycin DCLI5S9 Mechlorethamine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Mepacrine + Mitomycin DCJO08Q Mepacrine Amelanotic melanoma (Cell Line: MDA-MB-435) [6]
Mepacrine + Mitomycin DCJVUDA Mepacrine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Mepacrine + Mitomycin DCRUE9E Mepacrine Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Mercaptopurine + Mitomycin DCJ1NQL Mercaptopurine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Mercaptopurine + Mitomycin DC72IXI Mercaptopurine Glioma (Cell Line: SF-539) [4]
Mercaptopurine + Mitomycin DCSYAPN Mercaptopurine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Mercaptopurine + Mitomycin DCM38J6 Mercaptopurine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Mercaptopurine + Mitomycin DCSGSU8 Mercaptopurine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Methotrexate + Mitomycin DCUTT93 Methotrexate Anaplastic large cell lymphoma (Cell Line: SR) [4]
Methotrexate + Mitomycin DCNQZN6 Methotrexate Glioma (Cell Line: SF-295) [4]
Methotrexate + Mitomycin DCKW79H Methotrexate Melanoma (Cell Line: MALME-3M) [4]
Methotrexate + Mitomycin DCWYJIF Methotrexate Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Methotrexate + Mitomycin DCAFQBG Methotrexate Invasive ductal carcinoma (Cell Line: BT-549) [5]
Mitapivat + Mitomycin DCLGOAQ Mitapivat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Mitomycin + Pentostatin DCNB36D Pentostatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Mitomycin + Pentostatin DCZ7000 Pentostatin Astrocytoma (Cell Line: SNB-19) [4]
Mitomycin + Pentostatin DCHBSUW Pentostatin Glioma (Cell Line: SF-539) [4]
Mitomycin + Pentostatin DC912TA Pentostatin Glioma (Cell Line: SF-268) [4]
Mitomycin + PD-0325901 DCV4WI9 PD-0325901 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + AT13387 DCQ38N8 AT13387 Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Ixabepilone DC49DYI Ixabepilone Adenocarcinoma (Cell Line: HCT-15) [4]
Mitomycin + Ixabepilone DCW9A22 Ixabepilone Astrocytoma (Cell Line: U251) [4]
Mitomycin + Lapatinib DC1RR9V Lapatinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + MK-1775 DCK7635 MK-1775 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + JQ1 DCVU9CT JQ1 Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Carfilzomib DC2PDKP Carfilzomib Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + PMID28460551-Compound-2 DCYB5IS PMID28460551-Compound-2 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + Panobinostat DC3FL0O Panobinostat Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + RTB101 DCIKPT5 RTB101 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + SCH-900776 DCWWTUZ SCH-900776 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + Eltanexor oral DCASEI1 Eltanexor oral Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Formononetin DCZG24A Formononetin Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Everolimus DC6YO7H Everolimus Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Abexinostat DC90B5Y Abexinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Mitomycin + GDC-0084 DC3504I GDC-0084 Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Pralatrexate DCQ6FZJ Pralatrexate Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + SNX-2112 DCGFJPE SNX-2112 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + SCH 727965 DCS0GM9 SCH 727965 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + Ifosfamide DC8OY4T Ifosfamide Anaplastic large cell lymphoma (Cell Line: SR) [4]
Mitomycin + Ifosfamide DCXSYTV Ifosfamide Chronic myelogenous leukemia (Cell Line: K-562) [4]
Mitomycin + Ifosfamide DCESEPH Ifosfamide Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Mitomycin + Docetaxel DCJN23U Docetaxel Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + THAPSIGARGIN DCHU26C THAPSIGARGIN Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Etoposide DC2X4HV Etoposide Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + MK-5108 DCDTMU8 MK-5108 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + SNDX-275 DC8C7LW SNDX-275 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Mitomycin + Ridaforolimus DCZI8HN Ridaforolimus Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + MK-4827 DCEJA4Z MK-4827 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + Idarubicin DCRS0WL Idarubicin Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + Bortezomib DC4KBL7 Bortezomib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + Bortezomib DCX5TPY Bortezomib Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Mitomycin + Bardoxolone methyl DCOY1NR Bardoxolone methyl Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + TG100801 DC35CE8 TG100801 Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Lestaurtinib DCX8X8P Lestaurtinib Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Citarinostat DCGGFSM Citarinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Mitomycin + Cisplatin DCU2RBW Cisplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Mitomycin + Cisplatin DCLBNFX Cisplatin Anaplastic large cell lymphoma (Cell Line: SR) [4]
Mitomycin + Chlorambucil DC3PNAT Chlorambucil Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Mitomycin + ER819762 DC1ZN2K ER819762 Astrocytoma (Cell Line: U251) [4]
Mitomycin + ER819762 DC80WV6 ER819762 Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Mitomycin + ER819762 DCIVUPO ER819762 Clear cell renal cell carcinoma (Cell Line: A498) [4]
Mitomycin + ER819762 DC3S55C ER819762 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Mitomycin + ER819762 DC5KOVS ER819762 Glioma (Cell Line: SF-539) [4]
Mitomycin + ER819762 DCYG77E ER819762 Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Mitomycin + MK-2206 DCN81SM MK-2206 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [4]
Mitomycin + Romidepsin DCA85TX Romidepsin Ewing sarcoma (Cell Line: TC-71) [4]
Mitomycin + Ibrutinib DC5RB6N Ibrutinib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Mitomycin + Pentostatin DC8QGOV Pentostatin Carcinoma (Cell Line: MCF7) [5]
Mitomycin + PD-0325901 DCRF46C PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + PD-0325901 DCV7GWW PD-0325901 Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + PD-0325901 DCB0N4P PD-0325901 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + PD-0325901 DCVWRZZ PD-0325901 Carcinoma (Cell Line: OV90) [5]
Mitomycin + PD-0325901 DC406B7 PD-0325901 Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + PD-0325901 DC0ZYZJ PD-0325901 Carcinoma (Cell Line: MDAMB436) [5]
Mitomycin + PD-0325901 DCYCXYP PD-0325901 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + PD-0325901 DCFJ2HS PD-0325901 Colon carcinoma (Cell Line: RKO) [5]
Mitomycin + PD-0325901 DCPH4KH PD-0325901 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + PD-0325901 DCAJIB6 PD-0325901 Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + Lapatinib DCZY3EK Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Mitomycin + Lapatinib DC2S0N8 Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + Lapatinib DC4MJ2N Lapatinib Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + Lapatinib DCDSM28 Lapatinib Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + Lapatinib DCCMRMZ Lapatinib Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + Lapatinib DCR61I6 Lapatinib Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + Lapatinib DCAO0MG Lapatinib Colon carcinoma (Cell Line: RKO) [5]
Mitomycin + Lapatinib DCA3I4L Lapatinib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + Lapatinib DCVIRLG Lapatinib Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + MK-1775 DC7RKW8 MK-1775 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + MK-1775 DCATEAT MK-1775 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + MK-1775 DCQ3H1D MK-1775 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + MK-1775 DC8QFU0 MK-1775 Colon carcinoma (Cell Line: RKO) [5]
Mitomycin + PMID28460551-Compound-2 DCQRF0C PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Mitomycin + PMID28460551-Compound-2 DC6240I PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + PMID28460551-Compound-2 DCNV46K PMID28460551-Compound-2 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + PMID28460551-Compound-2 DC4U0YS PMID28460551-Compound-2 Carcinoma (Cell Line: OV90) [5]
Mitomycin + PMID28460551-Compound-2 DC7O2HK PMID28460551-Compound-2 Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + PMID28460551-Compound-2 DC6ZF7F PMID28460551-Compound-2 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + PMID28460551-Compound-2 DCGR8JL PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + PMID28460551-Compound-2 DCE5KXK PMID28460551-Compound-2 Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + Arsenic trioxide DCXMJXN Arsenic trioxide Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + RTB101 DCK8MUW RTB101 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + RTB101 DCOHUWC RTB101 Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + RTB101 DCVYJ9L RTB101 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + RTB101 DCL4HCM RTB101 Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + RTB101 DCI16HP RTB101 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + RTB101 DCSVLFS RTB101 Colon carcinoma (Cell Line: RKO) [5]
Mitomycin + RTB101 DC55PDF RTB101 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + RTB101 DCLAQNO RTB101 Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + SCH-900776 DCKNSXS SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Mitomycin + SCH-900776 DCQ8SDD SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + SCH-900776 DC3DMYF SCH-900776 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + SCH-900776 DCDC11P SCH-900776 Carcinoma (Cell Line: MDAMB436) [5]
Mitomycin + SCH-900776 DCDY965 SCH-900776 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + SCH-900776 DCSSTXZ SCH-900776 Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + SNX-2112 DCOFTQF SNX-2112 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Mitomycin + SNX-2112 DCXWZ7S SNX-2112 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + SNX-2112 DCZISN6 SNX-2112 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + SNX-2112 DCTKGJ8 SNX-2112 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + SNX-2112 DCA41PU SNX-2112 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + SNX-2112 DC0PRE9 SNX-2112 Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + SCH 727965 DC4HDUC SCH 727965 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + SCH 727965 DCUWVQD SCH 727965 Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + SCH 727965 DCNZ0YD SCH 727965 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + SCH 727965 DCXFKLD SCH 727965 Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + SCH 727965 DCJ3BAG SCH 727965 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + Erlotinib DCFNYLH Erlotinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + Ifosfamide DCK82K4 Ifosfamide Carcinoma (Cell Line: MCF7) [5]
Mitomycin + Ifosfamide DC7JXP6 Ifosfamide Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Mitomycin + Ifosfamide DCCSSLT Ifosfamide Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + MK-5108 DCW5EAA MK-5108 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + MK-5108 DCUK3G5 MK-5108 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + Ridaforolimus DCK57KE Ridaforolimus Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Mitomycin + Ridaforolimus DCLB655 Ridaforolimus Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + Ridaforolimus DCALZ0F Ridaforolimus Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + Ridaforolimus DCMWDDH Ridaforolimus Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + Ridaforolimus DC4K55M Ridaforolimus Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + Ridaforolimus DCROOK2 Ridaforolimus Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + Ridaforolimus DC16S4W Ridaforolimus Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + MK-4827 DCC21YY MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Mitomycin + MK-4827 DCGI4KS MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + MK-4827 DC6ZSD4 MK-4827 Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + MK-4827 DC5EIKS MK-4827 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + MK-4827 DCNMCS4 MK-4827 Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + MK-4827 DC2KD4U MK-4827 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + MK-4827 DCG9WT3 MK-4827 Colon carcinoma (Cell Line: RKO) [5]
Mitomycin + MK-4827 DCAN8K3 MK-4827 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + Idarubicin DC7FHVJ Idarubicin Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + Bortezomib DCEA8TE Bortezomib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + Bortezomib DCHDJ85 Bortezomib Carcinoma (Cell Line: EFM192B) [5]
Mitomycin + Bortezomib DCW48UB Bortezomib Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + GSK525762 DCSPHOB GSK525762 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Mitomycin + GSK525762 DCET7BG GSK525762 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + GSK525762 DC7VVBH GSK525762 Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + Cisplatin DCG8LIY Cisplatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Mitomycin + Chlorambucil DCIFGGU Chlorambucil Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + Sorafenib DCX0W2S Sorafenib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + ER819762 DC59EHQ ER819762 Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Mitomycin + ER819762 DCOWEUZ ER819762 Colon adenocarcinoma (Cell Line: COLO 205) [5]
Mitomycin + ER819762 DCBIHKE ER819762 Colon carcinoma (Cell Line: KM12) [5]
Mitomycin + ER819762 DCYS70R ER819762 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + MK-2206 DC2FZ1C MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + MK-2206 DCXG3UA MK-2206 Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + MK-2206 DCWZZDQ MK-2206 Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + MK-2206 DCXZ92M MK-2206 Carcinoma (Cell Line: OV90) [5]
Mitomycin + MK-2206 DCEREJI MK-2206 Carcinoma (Cell Line: MDAMB436) [5]
Mitomycin + MK-2206 DCLGC41 MK-2206 Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + MK-2206 DC8DN2F MK-2206 Colon carcinoma (Cell Line: RKO) [5]
Mitomycin + MK-2206 DC6RKXO MK-2206 Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + Dasatinib DCCIMFE Dasatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Mitomycin + Dasatinib DCUS90H Dasatinib Breast carcinoma (Cell Line: KPL1) [5]
Mitomycin + Dasatinib DCML89V Dasatinib Breast carcinoma (Cell Line: OCUBM) [5]
Mitomycin + Dasatinib DCOZDAB Dasatinib Colon adenocarcinoma (Cell Line: LOVO) [5]
Mitomycin + Dasatinib DCI8ULC Dasatinib Colon carcinoma (Cell Line: RKO) [5]
Mitomycin + Dasatinib DC6C71W Dasatinib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Mitomycin + Dasatinib DC6CG1X Dasatinib Rectal adenocarcinoma (Cell Line: SW837) [5]
Mitomycin + Pentostatin DC8VX4L Pentostatin Adenocarcinoma (Cell Line: HCC-2998) [6]
Mitomycin + Pentostatin DC6GRZQ Pentostatin Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Mitomycin + Pentostatin DCYW788 Pentostatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Mitomycin + Ruxolitinib DC1G2JB Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [6]
Mitomycin + Ruxolitinib DCHZ431 Ruxolitinib Hodgkin lymphoma (Cell Line: HDLM-2) [6]
Mitomycin + PD-0325901 DCD5H77 PD-0325901 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + PD-0325901 DCSZC0X PD-0325901 Adenocarcinoma (Cell Line: OVCAR3) [6]
Mitomycin + PD-0325901 DCIHP4O PD-0325901 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + PD-0325901 DCITH2O PD-0325901 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + PD-0325901 DCIP9QH PD-0325901 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + PD-0325901 DCIM1KN PD-0325901 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + PD-0325901 DCJC6U8 PD-0325901 Adenocarcinoma (Cell Line: NCIH520) [6]
Mitomycin + PD-0325901 DCK5UUF PD-0325901 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + PD-0325901 DC8YUWU PD-0325901 Adenocarcinoma (Cell Line: DLD1) [6]
Mitomycin + PD-0325901 DC377VW PD-0325901 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + PD-0325901 DCQEL2Y PD-0325901 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + PD-0325901 DCKZZVJ PD-0325901 Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + PD-0325901 DC7GN09 PD-0325901 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + PD-0325901 DCBEYEA PD-0325901 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + PD-0325901 DCSW3WB PD-0325901 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + PD-0325901 DC7PHVP PD-0325901 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + PD-0325901 DCHLMJ3 PD-0325901 Malignant melanoma (Cell Line: HT144) [6]
Mitomycin + PD-0325901 DCG5M1V PD-0325901 Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + PD-0325901 DCI10O3 PD-0325901 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + PD-0325901 DC6Q4J1 PD-0325901 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + PD-0325901 DCM91WH PD-0325901 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + PD-0325901 DCKJNM7 PD-0325901 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + PD-0325901 DCTT5FO PD-0325901 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Mitomycin + PD-0325901 DCFBTOF PD-0325901 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + Lapatinib DCH1QKG Lapatinib Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + Lapatinib DCK0DIT Lapatinib Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + Lapatinib DCDJP44 Lapatinib Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + Lapatinib DC8CVU7 Lapatinib Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + Lapatinib DCIXZ62 Lapatinib Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + Lapatinib DC0NAIU Lapatinib Adenocarcinoma (Cell Line: NCIH520) [6]
Mitomycin + Lapatinib DCE5MPO Lapatinib Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + Lapatinib DCT57RP Lapatinib Adenocarcinoma (Cell Line: DLD1) [6]
Mitomycin + Lapatinib DC6LFUS Lapatinib Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + Lapatinib DCZ3W8J Lapatinib Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + Lapatinib DCHLIM0 Lapatinib Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + Lapatinib DCJOSTQ Lapatinib Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + Lapatinib DCZEEI2 Lapatinib Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + Lapatinib DC3PMPY Lapatinib Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + Lapatinib DCTGAG4 Lapatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + MK-1775 DCVV9VP MK-1775 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + MK-1775 DC4FJT9 MK-1775 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + MK-1775 DCSX5PI MK-1775 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + MK-1775 DCNWPVW MK-1775 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + MK-1775 DC3O73X MK-1775 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + MK-1775 DCJMD43 MK-1775 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + MK-1775 DC9QQIY MK-1775 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + MK-1775 DCXJJED MK-1775 Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + MK-1775 DCKPEAG MK-1775 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + MK-1775 DCNXV16 MK-1775 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + MK-1775 DCKUQ53 MK-1775 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + MK-1775 DCIC1O9 MK-1775 Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + MK-1775 DCZNK2N MK-1775 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + MK-1775 DCFX2QR MK-1775 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + MK-1775 DCONMV4 MK-1775 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + MK-1775 DC6BYI0 MK-1775 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + PMID28460551-Compound-2 DC3VZIY PMID28460551-Compound-2 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + PMID28460551-Compound-2 DC73SW1 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + PMID28460551-Compound-2 DCWP7N4 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + PMID28460551-Compound-2 DCXHPGU PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + PMID28460551-Compound-2 DCZJOQK PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + PMID28460551-Compound-2 DCNVTXX PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH520) [6]
Mitomycin + PMID28460551-Compound-2 DC1MGNG PMID28460551-Compound-2 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + PMID28460551-Compound-2 DCMVW3Z PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + PMID28460551-Compound-2 DCNKTI3 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + PMID28460551-Compound-2 DC5YVPM PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + PMID28460551-Compound-2 DC2154S PMID28460551-Compound-2 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + PMID28460551-Compound-2 DC7E8OG PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + PMID28460551-Compound-2 DC8LGAT PMID28460551-Compound-2 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + PMID28460551-Compound-2 DCFMEX6 PMID28460551-Compound-2 Malignant melanoma (Cell Line: HT144) [6]
Mitomycin + PMID28460551-Compound-2 DC0PW6Z PMID28460551-Compound-2 Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + PMID28460551-Compound-2 DCO7MDT PMID28460551-Compound-2 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + PMID28460551-Compound-2 DCIM5LI PMID28460551-Compound-2 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + PMID28460551-Compound-2 DCUL2KT PMID28460551-Compound-2 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + PMID28460551-Compound-2 DCW3HUB PMID28460551-Compound-2 Non small cell carcinoma (Cell Line: SKMES1) [6]
Mitomycin + PMID28460551-Compound-2 DCRSCC2 PMID28460551-Compound-2 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + PMID28460551-Compound-2 DCDJ1Y9 PMID28460551-Compound-2 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Mitomycin + PMID28460551-Compound-2 DCY91BU PMID28460551-Compound-2 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + PMID28460551-Compound-2 DCPBLAJ PMID28460551-Compound-2 Prostate carcinoma (Cell Line: LNCAP) [6]
Mitomycin + Arsenic trioxide DCSBR41 Arsenic trioxide Adenocarcinoma (Cell Line: HCT-15) [6]
Mitomycin + Arsenic trioxide DCHNWI4 Arsenic trioxide Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + Arsenic trioxide DCU4W0J Arsenic trioxide Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Mitomycin + Arsenic trioxide DCBQXHJ Arsenic trioxide Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + Arsenic trioxide DCA71W4 Arsenic trioxide Lung adenocarcinoma (Cell Line: HOP-62) [6]
Mitomycin + Arsenic trioxide DC2FQY1 Arsenic trioxide Malignant melanoma (Cell Line: LOX IMVI) [6]
Mitomycin + Arsenic trioxide DCIQTN2 Arsenic trioxide Melanoma (Cell Line: UACC-257) [6]
Mitomycin + RTB101 DC9M8WR RTB101 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + RTB101 DC3MM4R RTB101 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + RTB101 DCC5KW4 RTB101 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + RTB101 DC2PEHD RTB101 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + RTB101 DC8DCA7 RTB101 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + RTB101 DCB5VFW RTB101 Adenocarcinoma (Cell Line: NCIH520) [6]
Mitomycin + RTB101 DC3XOTO RTB101 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + RTB101 DCXS277 RTB101 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + RTB101 DCS9G7D RTB101 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + RTB101 DCVS08X RTB101 Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + RTB101 DCABD2S RTB101 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + RTB101 DCI0GIS RTB101 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + RTB101 DCU7X6B RTB101 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + RTB101 DCKJPKL RTB101 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + RTB101 DCIU09T RTB101 Malignant melanoma (Cell Line: HT144) [6]
Mitomycin + RTB101 DCFL4Z3 RTB101 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + RTB101 DCBZ04G RTB101 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + RTB101 DCI58FG RTB101 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + RTB101 DC2TQ2W RTB101 Non small cell carcinoma (Cell Line: SKMES1) [6]
Mitomycin + RTB101 DCICKB5 RTB101 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + RTB101 DCFB33K RTB101 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Mitomycin + RTB101 DC358J9 RTB101 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + RTB101 DCX5RWL RTB101 Prostate carcinoma (Cell Line: LNCAP) [6]
Mitomycin + SCH-900776 DCM8M9P SCH-900776 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + SCH-900776 DCE6M2R SCH-900776 Adenocarcinoma (Cell Line: OVCAR3) [6]
Mitomycin + SCH-900776 DC0IWOZ SCH-900776 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + SCH-900776 DCQWTEN SCH-900776 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + SCH-900776 DC0VJFT SCH-900776 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + SCH-900776 DC0WWCS SCH-900776 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + SCH-900776 DCQO1II SCH-900776 Adenocarcinoma (Cell Line: NCIH520) [6]
Mitomycin + SCH-900776 DCJZ50T SCH-900776 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + SCH-900776 DCL2REM SCH-900776 Adenocarcinoma (Cell Line: DLD1) [6]
Mitomycin + SCH-900776 DCQJ7FA SCH-900776 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + SCH-900776 DCN3Q4A SCH-900776 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + SCH-900776 DCR563N SCH-900776 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + SCH-900776 DCFAKT0 SCH-900776 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + SCH-900776 DCAPUX5 SCH-900776 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + SCH-900776 DCAMYPR SCH-900776 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + SCH-900776 DCY1UT9 SCH-900776 Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + SCH-900776 DCPZ84A SCH-900776 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + SCH-900776 DC5RXJP SCH-900776 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + SCH-900776 DCH9SQB SCH-900776 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + SCH-900776 DCFYHRG SCH-900776 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + SCH-900776 DCMRKLU SCH-900776 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Mitomycin + SCH-900776 DCBIECC SCH-900776 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + Eltanexor oral DCD8U8A Eltanexor oral Hodgkin lymphoma (Cell Line: U-HO1) [6]
Mitomycin + Formononetin DCTYVU7 Formononetin Hodgkin lymphoma (Cell Line: U-HO1) [6]
Mitomycin + SNX-2112 DCG6AHM SNX-2112 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + SNX-2112 DCEVAVX SNX-2112 Adenocarcinoma (Cell Line: OVCAR3) [6]
Mitomycin + SNX-2112 DCMJACE SNX-2112 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + SNX-2112 DC2QPQO SNX-2112 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + SNX-2112 DCE0BVH SNX-2112 Adenocarcinoma (Cell Line: DLD1) [6]
Mitomycin + SNX-2112 DCXO3HF SNX-2112 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + SNX-2112 DC5IG6K SNX-2112 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + SNX-2112 DC97OPA SNX-2112 Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + SNX-2112 DCTY7RB SNX-2112 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + SNX-2112 DCFHKU3 SNX-2112 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + SNX-2112 DCTN1BL SNX-2112 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + SNX-2112 DC0N06K SNX-2112 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + SNX-2112 DCKF2BI SNX-2112 Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + SNX-2112 DC0MIWT SNX-2112 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + SNX-2112 DC5M25J SNX-2112 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + SCH 727965 DCEYV7Z SCH 727965 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + SCH 727965 DCG93NK SCH 727965 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + SCH 727965 DCSM2M7 SCH 727965 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + SCH 727965 DCCJBS9 SCH 727965 Adenocarcinoma (Cell Line: NCIH520) [6]
Mitomycin + SCH 727965 DCI5X3U SCH 727965 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + SCH 727965 DCHW4K6 SCH 727965 Adenocarcinoma (Cell Line: DLD1) [6]
Mitomycin + SCH 727965 DCYC2JR SCH 727965 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + SCH 727965 DCGCYU4 SCH 727965 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + SCH 727965 DC0410N SCH 727965 Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + SCH 727965 DCOHRQV SCH 727965 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + SCH 727965 DCNH1Z8 SCH 727965 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + SCH 727965 DCPB27R SCH 727965 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + SCH 727965 DC5UFGA SCH 727965 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + SCH 727965 DC1SP1I SCH 727965 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + SCH 727965 DCOQ9MX SCH 727965 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + SCH 727965 DC0CSC5 SCH 727965 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + SCH 727965 DCWOYSC SCH 727965 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + SCH 727965 DC96PIK SCH 727965 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Mitomycin + SCH 727965 DCJOLNN SCH 727965 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + Erlotinib DCR23NK Erlotinib Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + Ifosfamide DCO5JR1 Ifosfamide Adenocarcinoma (Cell Line: DU-145) [6]
Mitomycin + Ifosfamide DCPXCMG Ifosfamide Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + Ifosfamide DCZO39Y Ifosfamide Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Mitomycin + Ifosfamide DCT8WQ6 Ifosfamide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Mitomycin + Etoposide DC4RP6V Etoposide Hodgkin lymphoma (Cell Line: U-HO1) [6]
Mitomycin + MK-5108 DCQ6MIY MK-5108 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + MK-5108 DCS2JLQ MK-5108 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + MK-5108 DCBDO84 MK-5108 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + MK-5108 DCBGT33 MK-5108 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + MK-5108 DCMWDYE MK-5108 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + MK-5108 DCIFDF1 MK-5108 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + MK-5108 DCVIHQZ MK-5108 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + SNX-5422 DC7GDHL SNX-5422 Hodgkin lymphoma (Cell Line: L-1236) [6]
Mitomycin + Ridaforolimus DCE0MFI Ridaforolimus Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + Ridaforolimus DC4W5KV Ridaforolimus Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + Ridaforolimus DC4KMN2 Ridaforolimus Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + Ridaforolimus DC8ZW1T Ridaforolimus Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + Ridaforolimus DCUGYGG Ridaforolimus Adenocarcinoma (Cell Line: NCIH520) [6]
Mitomycin + Ridaforolimus DCTBOPL Ridaforolimus Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + Ridaforolimus DCLKW9U Ridaforolimus Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + Ridaforolimus DC00GL3 Ridaforolimus Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + Ridaforolimus DCXKF2J Ridaforolimus Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + Ridaforolimus DCRWUP5 Ridaforolimus Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + Ridaforolimus DC6CJSL Ridaforolimus Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + Ridaforolimus DC7JUBY Ridaforolimus Malignant melanoma (Cell Line: A375) [6]
Mitomycin + Ridaforolimus DCDVWKF Ridaforolimus Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + Ridaforolimus DC2IZB4 Ridaforolimus Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + Ridaforolimus DCF9C0D Ridaforolimus Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + Ridaforolimus DCKSNEG Ridaforolimus Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + Ridaforolimus DCH60UY Ridaforolimus Prostate carcinoma (Cell Line: LNCAP) [6]
Mitomycin + MK-4827 DC9DNKB MK-4827 Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + MK-4827 DCJ9WP9 MK-4827 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + MK-4827 DCA95HN MK-4827 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + MK-4827 DCW7RTJ MK-4827 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + MK-4827 DC03FZE MK-4827 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + MK-4827 DCEAMXD MK-4827 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + MK-4827 DCPZS2L MK-4827 Adenocarcinoma (Cell Line: DLD1) [6]
Mitomycin + MK-4827 DCQXX3K MK-4827 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + MK-4827 DCAY2F1 MK-4827 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + MK-4827 DCRWMKZ MK-4827 Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + MK-4827 DC1513C MK-4827 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + MK-4827 DC336YK MK-4827 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + MK-4827 DCT0MHX MK-4827 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + MK-4827 DC2TJSI MK-4827 Malignant melanoma (Cell Line: A375) [6]
Mitomycin + MK-4827 DCE7R7O MK-4827 Malignant melanoma (Cell Line: HT144) [6]
Mitomycin + MK-4827 DC16URR MK-4827 Malignant melanoma (Cell Line: SKMEL30) [6]
Mitomycin + MK-4827 DC9LH6A MK-4827 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + MK-4827 DC49DOV MK-4827 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + MK-4827 DC4PM32 MK-4827 Non small cell carcinoma (Cell Line: SKMES1) [6]
Mitomycin + MK-4827 DCA9BSY MK-4827 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + MK-4827 DCWK6BD MK-4827 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Mitomycin + MK-4827 DCTGNT5 MK-4827 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + Idarubicin DCKYOFW Idarubicin Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + Idarubicin DCIMCD1 Idarubicin Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + Idarubicin DCHS1CN Idarubicin Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + Idarubicin DCK6OKC Idarubicin Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + Idarubicin DC1TXYJ Idarubicin Malignant melanoma (Cell Line: A375) [6]
Mitomycin + Idarubicin DCQAWG6 Idarubicin Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + Idarubicin DCP4XKC Idarubicin Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + Idarubicin DCWN4I2 Idarubicin Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + Bortezomib DC6Q9FU Bortezomib Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + Bortezomib DC2I58Y Bortezomib Adenocarcinoma (Cell Line: OVCAR3) [6]
Mitomycin + Bortezomib DCMU880 Bortezomib Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + Bortezomib DCQLDQ5 Bortezomib Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + Bortezomib DCDDJFT Bortezomib Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + Bortezomib DC4HLHP Bortezomib Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + Bortezomib DCNT3RI Bortezomib Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + Bortezomib DCBCTTI Bortezomib Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + Bortezomib DCL649X Bortezomib Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + Bortezomib DCOHYQM Bortezomib Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + Bortezomib DCPVQJS Bortezomib Hodgkin lymphoma (Cell Line: L-1236) [6]
Mitomycin + Bortezomib DC2TSAU Bortezomib Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + Bortezomib DCDHLB6 Bortezomib Malignant melanoma (Cell Line: A375) [6]
Mitomycin + Bortezomib DCNT7UZ Bortezomib Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + Bortezomib DC3DWSS Bortezomib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + Bortezomib DCHZFOG Bortezomib Prostate carcinoma (Cell Line: LNCAP) [6]
Mitomycin + Bardoxolone methyl DCPDGVH Bardoxolone methyl Hodgkin lymphoma (Cell Line: U-HO1) [6]
Mitomycin + GSK525762 DCM557O GSK525762 Adenocarcinoma (Cell Line: OVCAR3) [6]
Mitomycin + GSK525762 DCTT1ID GSK525762 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + GSK525762 DC5U31T GSK525762 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + Cisplatin DCKFS3O Cisplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [6]
Mitomycin + Cisplatin DCNQNUW Cisplatin Melanoma (Cell Line: MALME-3M) [6]
Mitomycin + Cisplatin DC0BT85 Cisplatin Melanoma (Cell Line: SK-MEL-2) [6]
Mitomycin + Chlorambucil DCVIH93 Chlorambucil Adenocarcinoma (Cell Line: HCT-15) [6]
Mitomycin + Chlorambucil DCC3NXO Chlorambucil High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [6]
Mitomycin + Chlorambucil DCGUZFY Chlorambucil Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + Chlorambucil DCWKJPC Chlorambucil Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
Mitomycin + Sorafenib DCVRQQ4 Sorafenib Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + ER819762 DC18QUL ER819762 Adenocarcinoma (Cell Line: OVCAR3) [6]
Mitomycin + ER819762 DCQUD0M ER819762 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + ER819762 DC13B16 ER819762 Adenocarcinoma (Cell Line: HCT-15) [6]
Mitomycin + ER819762 DCE8LFJ ER819762 Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Mitomycin + ER819762 DCW866Y ER819762 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [6]
Mitomycin + ER819762 DCJE4G4 ER819762 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + ER819762 DCPXNDZ ER819762 Melanoma (Cell Line: SK-MEL-2) [6]
Mitomycin + ER819762 DC95I8M ER819762 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Mitomycin + PF-562271 DC0LPCV PF-562271 Hodgkin lymphoma (Cell Line: U-HO1) [6]
Mitomycin + MK-2206 DC31C93 MK-2206 Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + MK-2206 DCPPYFV MK-2206 Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + MK-2206 DCU0QRR MK-2206 Adenocarcinoma (Cell Line: NCIH2122) [6]
Mitomycin + MK-2206 DCXJ990 MK-2206 Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + MK-2206 DC6L7D8 MK-2206 Adenocarcinoma (Cell Line: COLO320DM) [6]
Mitomycin + MK-2206 DC0VZIX MK-2206 Adenocarcinoma (Cell Line: HCT116) [6]
Mitomycin + MK-2206 DCVE92R MK-2206 Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + MK-2206 DCDXSA7 MK-2206 Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + MK-2206 DC0ZOK0 MK-2206 Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + MK-2206 DCDGPUI MK-2206 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Mitomycin + MK-2206 DC1LPOS MK-2206 Malignant melanoma (Cell Line: HT144) [6]
Mitomycin + MK-2206 DCTS4N9 MK-2206 Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + MK-2206 DCHLQU3 MK-2206 Malignant melanoma (Cell Line: UACC62) [6]
Mitomycin + MK-2206 DCBMWMM MK-2206 Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + MK-2206 DC49XY5 MK-2206 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
Mitomycin + MK-2206 DCCHF40 MK-2206 Prostate carcinoma (Cell Line: VCAP) [6]
Mitomycin + Doxorubicin DCZ0LQS Doxorubicin Hodgkin lymphoma (Cell Line: L-1236) [6]
Mitomycin + BGT226 DCD3J1R BGT226 Hodgkin lymphoma (Cell Line: L-1236) [6]
Mitomycin + Dasatinib DC9MFFE Dasatinib Adenocarcinoma (Cell Line: CAOV3) [6]
Mitomycin + Dasatinib DCLK8KQ Dasatinib Adenocarcinoma (Cell Line: OVCAR3) [6]
Mitomycin + Dasatinib DCG3NVY Dasatinib Adenocarcinoma (Cell Line: A427) [6]
Mitomycin + Dasatinib DC6Y3U4 Dasatinib Adenocarcinoma (Cell Line: NCIH1650) [6]
Mitomycin + Dasatinib DCUOYL9 Dasatinib Adenocarcinoma (Cell Line: NCIH23) [6]
Mitomycin + Dasatinib DCIDAL9 Dasatinib Adenocarcinoma (Cell Line: DLD1) [6]
Mitomycin + Dasatinib DCE02N1 Dasatinib Adenocarcinoma (Cell Line: HT29) [6]
Mitomycin + Dasatinib DCZO91F Dasatinib Adenocarcinoma (Cell Line: SW-620) [6]
Mitomycin + Dasatinib DCBIVA6 Dasatinib Amelanotic melanoma (Cell Line: A2058) [6]
Mitomycin + Dasatinib DCAGHXL Dasatinib Germ cell tumour (Cell Line: PA1) [6]
Mitomycin + Dasatinib DCOTG29 Dasatinib Malignant melanoma (Cell Line: A375) [6]
Mitomycin + Dasatinib DCIHWXA Dasatinib Malignant melanoma (Cell Line: RPMI7951) [6]
Mitomycin + Dasatinib DCCH8F7 Dasatinib Mesothelioma (Cell Line: MSTO) [6]
Mitomycin + Dasatinib DCYA9Q9 Dasatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [6]
MK-1775 + Mitomycin DC9DB2U MK-1775 Ewing sarcoma (Cell Line: TC-71) [4]
MK-2206 + Mitomycin DC9EY3T MK-2206 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
MK-2206 + Mitomycin DCZ977D MK-2206 Ewing sarcoma (Cell Line: TC-71) [4]
MK-2206 + Mitomycin DC8HD2X MK-2206 Hodgkin lymphoma (Cell Line: U-HO1) [4]
Momelotinib + Mitomycin DCOMYRD Momelotinib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Nilotinib + Mitomycin DCWEZ6F Nilotinib Glioma (Cell Line: SF-295) [4]
Nilotinib + Mitomycin DC0WB05 Nilotinib Colon carcinoma (Cell Line: KM12) [5]
Nilotinib + Mitomycin DCCFP0Z Nilotinib Adenocarcinoma (Cell Line: OVCAR3) [6]
Nilotinib + Mitomycin DCOGROB Nilotinib Adenocarcinoma (Cell Line: HCT-15) [6]
Nilotinib + Mitomycin DCW02QR Nilotinib Adenocarcinoma (Cell Line: HCC-2998) [6]
Nilotinib + Mitomycin DC9TI6B Nilotinib Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Nilotinib + Mitomycin DCAQ632 Nilotinib Lung adenocarcinoma (Cell Line: EKVX) [6]
Nintedanib + Mitomycin DCGWK16 Nintedanib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
NVP-AUY922 + Mitomycin DCXFWJS NVP-AUY922 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
NVP-AUY922 + Mitomycin DCK4H0K NVP-AUY922 Ewing sarcoma (Cell Line: TC-71) [4]
Omeprazole + Mitomycin DC1UADJ Omeprazole Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
ONC201 + Mitomycin DC4LZ7H ONC201 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
OSI-027 + Mitomycin DCLHT13 OSI-027 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Pacritinib + Mitomycin DCRA3UE Pacritinib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Panobinostat + Mitomycin DCMVIJJ Panobinostat Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Panobinostat + Mitomycin DCIB1DN Panobinostat Ewing sarcoma (Cell Line: TC-71) [4]
PD-0325901 + Mitomycin DCX0M44 PD-0325901 Hodgkin lymphoma (Cell Line: U-HO1) [6]
PD166285 + Mitomycin DCV782D PD166285 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Pelitinib + Mitomycin DC1LNQ1 Pelitinib Ewing sarcoma (Cell Line: TC-71) [4]
Perifosine + Mitomycin DCSVPBG Perifosine Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
PF-228 + Mitomycin DC4EHZI PF-228 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
PF-477736 + Mitomycin DCIIAM2 PF-477736 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
PHA-690509 + Mitomycin DC2KIZ1 PHA-690509 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
PHA-793887 + Mitomycin DCASNB3 PHA-793887 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Picoplatin + Mitomycin DCUT0O8 Picoplatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Picoplatin + Mitomycin DCTXP4B Picoplatin Carcinoma (Cell Line: RXF 393) [5]
Picoplatin + Mitomycin DC5XI9G Picoplatin Colon carcinoma (Cell Line: KM12) [5]
Picoplatin + Mitomycin DCDSF4J Picoplatin Amelanotic melanoma (Cell Line: M14) [6]
Picoplatin + Mitomycin DCKT9YT Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Picoplatin + Mitomycin DCTC2RS Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Picoplatin + Mitomycin DCHYBMQ Picoplatin Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
Plicamycin + Mitomycin DCUSXDA Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [4]
Plicamycin + Mitomycin DC3IUFS Plicamycin Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Plicamycin + Mitomycin DC0FTIQ Plicamycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Plicamycin + Mitomycin DCDQCEN Plicamycin Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Plicamycin + Mitomycin DCWCX1A Plicamycin Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Plicamycin + Mitomycin DCYV58A Plicamycin Colon carcinoma (Cell Line: KM12) [5]
Plicamycin + Mitomycin DCLIJ97 Plicamycin Melanoma (Cell Line: UACC-257) [6]
Plicamycin + Mitomycin DC7TU2V Plicamycin Melanoma (Cell Line: MALME-3M) [6]
Plicamycin + Mitomycin DCJRTRC Plicamycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Plinabulin + Mitomycin DCYXR3J Plinabulin Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
PMID25656651-Compound-5 + Mitomycin DCQMM2V PMID25656651-Compound-5 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
PMID25656651-Compound-7 + Mitomycin DC2DLIS PMID25656651-Compound-7 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
PMID28460551-Compound-2 + Mitomycin DCG2V5U PMID28460551-Compound-2 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
PMID28460551-Compound-2 + Mitomycin DCXO8RD PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: K-562) [4]
PMID28460551-Compound-2 + Mitomycin DC24G71 PMID28460551-Compound-2 Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
PMID28460551-Compound-2 + Mitomycin DCYUD7H PMID28460551-Compound-2 Glioblastoma (Cell Line: SNB-75) [4]
PMID28460551-Compound-2 + Mitomycin DC3G62T PMID28460551-Compound-2 Plasma cell myeloma (Cell Line: RPMI-8226) [4]
PMID28460551-Compound-2 + Mitomycin DCEXDY8 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCC-2998) [6]
PMID28460551-Compound-2 + Mitomycin DCR08EP PMID28460551-Compound-2 Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
PMID28460551-Compound-2 + Mitomycin DCV3EY8 PMID28460551-Compound-2 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
PMID28460551-Compound-2 + Mitomycin DC820ZC PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: HOP-62) [6]
PMID28460551-Compound-2 + Mitomycin DCQXJSA PMID28460551-Compound-2 Malignant melanoma (Cell Line: UACC62) [6]
PMID28870136-Compound-43 + Mitomycin DCGO2BC PMID28870136-Compound-43 Clear cell renal cell carcinoma (Cell Line: A498) [4]
PMID28870136-Compound-43 + Mitomycin DCOGR3F PMID28870136-Compound-43 Glioma (Cell Line: SF-268) [4]
PMID28870136-Compound-43 + Mitomycin DCNO649 PMID28870136-Compound-43 Carcinoma (Cell Line: MCF7) [5]
PMID28870136-Compound-43 + Mitomycin DC9Y0S9 PMID28870136-Compound-43 Amelanotic melanoma (Cell Line: M14) [6]
PMID28870136-Compound-43 + Mitomycin DCPD2CN PMID28870136-Compound-43 Lung adenocarcinoma (Cell Line: NCI-H522) [6]
PMID28870136-Compound-43 + Mitomycin DC43QTA PMID28870136-Compound-43 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
PMID28870136-Compound-43 + Mitomycin DC3J325 PMID28870136-Compound-43 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Podofilox + Mitomycin DC41WDV Podofilox Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Pomalidomide + Mitomycin DCJXJCL Pomalidomide Adenocarcinoma (Cell Line: DU-145) [4]
Pomalidomide + Mitomycin DC3T8P5 Pomalidomide Adenocarcinoma (Cell Line: A549) [4]
Pomalidomide + Mitomycin DCPEVNP Pomalidomide Astrocytoma (Cell Line: SNB-19) [4]
Pomalidomide + Mitomycin DCPX2W6 Pomalidomide Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Pomalidomide + Mitomycin DCXZLRW Pomalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Pomalidomide + Mitomycin DCU9THN Pomalidomide Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Pomalidomide + Mitomycin DCYQIDI Pomalidomide Lung adenocarcinoma (Cell Line: HOP-62) [4]
Pomalidomide + Mitomycin DCZX7S7 Pomalidomide Lung adenocarcinoma (Cell Line: MDA-MB-231) [4]
Pomalidomide + Mitomycin DC5OTGW Pomalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Pomalidomide + Mitomycin DCY0MX1 Pomalidomide Renal cell carcinoma (Cell Line: SN12C) [4]
Pomalidomide + Mitomycin DC69JY5 Pomalidomide Carcinoma (Cell Line: MCF7) [5]
Pomalidomide + Mitomycin DCDMXAF Pomalidomide Colon adenocarcinoma (Cell Line: COLO 205) [5]
Pracinostat + Mitomycin DCNKF8H Pracinostat Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Pralatrexate + Mitomycin DCXM645 Pralatrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Pralatrexate + Mitomycin DCNIQGG Pralatrexate Chronic myelogenous leukemia (Cell Line: K-562) [4]
Pralatrexate + Mitomycin DCHIAGU Pralatrexate Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Pralatrexate + Mitomycin DC01YYT Pralatrexate Lung adenocarcinoma (Cell Line: HOP-62) [6]
Pralatrexate + Mitomycin DCM3DFA Pralatrexate Malignant melanoma (Cell Line: UACC62) [6]
PRT-060318 + Mitomycin DCA952R PRT-060318 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Raloxifene + Mitomycin DCGS38Q Raloxifene Astrocytoma (Cell Line: U251) [4]
Raloxifene + Mitomycin DCOKAVQ Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Raloxifene + Mitomycin DCFTRWW Raloxifene Glioma (Cell Line: SF-268) [4]
Raloxifene + Mitomycin DCCF5WV Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [5]
Raloxifene + Mitomycin DCXPSUY Raloxifene Invasive ductal carcinoma (Cell Line: T-47D) [5]
Raloxifene + Mitomycin DCR64HZ Raloxifene Adenocarcinoma (Cell Line: HCC-2998) [6]
Raloxifene + Mitomycin DC3QMKQ Raloxifene Adenocarcinoma (Cell Line: HCT116) [6]
Raloxifene + Mitomycin DCMTRBY Raloxifene Amelanotic melanoma (Cell Line: M14) [6]
Raloxifene + Mitomycin DCWJH3N Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Raloxifene + Mitomycin DCT5WSL Raloxifene Melanoma (Cell Line: SK-MEL-2) [6]
Raloxifene + Mitomycin DCV14UP Raloxifene Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
Romidepsin + Mitomycin DCXZJL2 Romidepsin Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Romidepsin + Mitomycin DCGKD24 Romidepsin Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Romidepsin + Mitomycin DCFQFM2 Romidepsin Ewing sarcoma (Cell Line: TC-71) [4]
Romidepsin + Mitomycin DCX9IQN Romidepsin Glioblastoma (Cell Line: SNB-75) [4]
Romidepsin + Mitomycin DCEZNO8 Romidepsin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Romidepsin + Mitomycin DCD2NAR Romidepsin Adenocarcinoma (Cell Line: DU-145) [6]
Romidepsin + Mitomycin DCFC41L Romidepsin Adenocarcinoma (Cell Line: OVCAR3) [6]
Romidepsin + Mitomycin DC4C24I Romidepsin Adenocarcinoma (Cell Line: NCIH23) [6]
Romidepsin + Mitomycin DC446C3 Romidepsin Adenocarcinoma (Cell Line: HT29) [6]
Romidepsin + Mitomycin DCYAYSK Romidepsin Adenocarcinoma (Cell Line: HCC-2998) [6]
Romidepsin + Mitomycin DCPR5MR Romidepsin Amelanotic melanoma (Cell Line: M14) [6]
Romidepsin + Mitomycin DC1JJUQ Romidepsin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Romidepsin + Mitomycin DC1IJG0 Romidepsin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [6]
Romidepsin + Mitomycin DC2OJG5 Romidepsin Lung adenocarcinoma (Cell Line: HOP-62) [6]
Romidepsin + Mitomycin DCGMVHT Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [6]
Romidepsin + Mitomycin DCB78ED Romidepsin Malignant melanoma (Cell Line: UACC62) [6]
Ruxolitinib + Mitomycin DCVSZEZ Ruxolitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [4]
Ruxolitinib + Mitomycin DCUJJJO Ruxolitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Ruxolitinib + Mitomycin DCQWGZH Ruxolitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Ruxolitinib + Mitomycin DCHAROU Ruxolitinib Carcinoma (Cell Line: RXF 393) [5]
Ruxolitinib + Mitomycin DC34S3N Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Ruxolitinib + Mitomycin DCTGYPT Ruxolitinib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Ruxolitinib + Mitomycin DCCP8DD Ruxolitinib Adenocarcinoma (Cell Line: HCT-15) [6]
Ruxolitinib + Mitomycin DCKS4RL Ruxolitinib Adenocarcinoma (Cell Line: SW-620) [6]
RWJ-67657 + Mitomycin DC3H1KH RWJ-67657 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Saracatinib + Mitomycin DCUOZJX Saracatinib Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
SB 224289 + Mitomycin DCFFLAN SB 224289 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
SCH 727965 + Mitomycin DCH9LDW SCH 727965 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
SCH 727965 + Mitomycin DC4XGZM SCH 727965 Amelanotic melanoma (Cell Line: M14) [6]
SCH 727965 + Mitomycin DC439XI SCH 727965 Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
Selumetinib + Mitomycin DCL322H Selumetinib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [4]
Sirolimus + Mitomycin DCYSF5I Sirolimus Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Sirolimus + Mitomycin DCPZVWJ Sirolimus Anaplastic large cell lymphoma (Cell Line: SR) [4]
Sirolimus + Mitomycin DCPETSV Sirolimus Glioma (Cell Line: SF-295) [4]
Sirolimus + Mitomycin DC4QS9O Sirolimus Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Sirolimus + Mitomycin DCUF6NO Sirolimus Invasive ductal carcinoma (Cell Line: BT-549) [5]
Sirolimus + Mitomycin DCDUCZ0 Sirolimus Adenocarcinoma (Cell Line: A549) [6]
Sirolimus + Mitomycin DCV2UA1 Sirolimus Adenocarcinoma (Cell Line: HCT-15) [6]
Sirolimus + Mitomycin DCZWROF Sirolimus Adenocarcinoma (Cell Line: SW-620) [6]
Sirolimus + Mitomycin DC57QFS Sirolimus High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Sirolimus + Mitomycin DC8JGN9 Sirolimus Malignant melanoma (Cell Line: UACC62) [6]
Sirolimus + Mitomycin DCF3MU7 Sirolimus Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Sirolimus + Mitomycin DC4OATE Sirolimus Prostate carcinoma (Cell Line: PC-3) [6]
Sorafenib + Mitomycin DCQ8RK3 Sorafenib Adenocarcinoma (Cell Line: DU-145) [4]
Sorafenib + Mitomycin DCSIX1F Sorafenib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Sorafenib + Mitomycin DCRETGN Sorafenib Lung adenocarcinoma (Cell Line: EKVX) [4]
Sorafenib + Mitomycin DCPT2GS Sorafenib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Sorafenib + Mitomycin DCSIZTH Sorafenib Prostate carcinoma (Cell Line: PC-3) [4]
Sorafenib + Mitomycin DCW6RIO Sorafenib Colon adenocarcinoma (Cell Line: COLO 205) [5]
SY-1425 + Mitomycin DCKFP0G SY-1425 Glioma (Cell Line: SF-539) [4]
SY-1425 + Mitomycin DC0CYUV SY-1425 Papillary renal cell carcinoma (Cell Line: ACHN) [4]
SY-1425 + Mitomycin DCJ8C9O SY-1425 Renal cell carcinoma (Cell Line: UO-31) [4]
SY-1425 + Mitomycin DCQEAK4 SY-1425 Invasive ductal carcinoma (Cell Line: HS 578T) [5]
SY-1425 + Mitomycin DCCWQME SY-1425 Adenocarcinoma (Cell Line: HT29) [6]
SY-1425 + Mitomycin DCE1IJV SY-1425 Lung adenocarcinoma (Cell Line: NCI-H522) [6]
SY-1425 + Mitomycin DC8L00U SY-1425 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Taxol + Mitomycin DCLMAVJ Taxol Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Taxol + Mitomycin DC6NW7G Taxol Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Taxol + Mitomycin DCWC3TT Taxol Adenocarcinoma (Cell Line: DU-145) [6]
Taxol + Mitomycin DCH1G4T Taxol Adenocarcinoma (Cell Line: SW-620) [6]
Taxol + Mitomycin DCE8EA7 Taxol Adenocarcinoma (Cell Line: HCT-15) [6]
Taxol + Mitomycin DCX80D5 Taxol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
TEM + Mitomycin DC7GF4E TEM Chronic myelogenous leukemia (Cell Line: K-562) [4]
TEM + Mitomycin DCIUO88 TEM Clear cell renal cell carcinoma (Cell Line: A498) [4]
TEM + Mitomycin DC30PFK TEM Renal cell carcinoma (Cell Line: UO-31) [4]
TEM + Mitomycin DC0551C TEM Colon carcinoma (Cell Line: KM12) [5]
TEM + Mitomycin DCQXNK8 TEM Invasive ductal carcinoma (Cell Line: T-47D) [5]
TEM + Mitomycin DCM3PFL TEM Adenocarcinoma (Cell Line: OVCAR3) [6]
TEM + Mitomycin DCXYE3Y TEM Adenocarcinoma (Cell Line: A549) [6]
TEM + Mitomycin DCOZ6MQ TEM Adenocarcinoma (Cell Line: HCC-2998) [6]
Terameprocol + Mitomycin DC93AIR Terameprocol Anaplastic large cell lymphoma (Cell Line: SR) [4]
Terameprocol + Mitomycin DCX20BX Terameprocol Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Terameprocol + Mitomycin DC0LFCZ Terameprocol Renal cell carcinoma (Cell Line: SN12C) [4]
Terameprocol + Mitomycin DCTZIC4 Terameprocol Adenocarcinoma (Cell Line: DU-145) [6]
Terameprocol + Mitomycin DCQMCWM Terameprocol Adenocarcinoma (Cell Line: OVCAR3) [6]
Terameprocol + Mitomycin DCIGM1C Terameprocol Adenocarcinoma (Cell Line: A549) [6]
Terameprocol + Mitomycin DCIYWBU Terameprocol Adenocarcinoma (Cell Line: HCC-2998) [6]
Terameprocol + Mitomycin DCGHHUO Terameprocol Adenocarcinoma (Cell Line: HT29) [6]
Terameprocol + Mitomycin DCTZ0U1 Terameprocol Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Terameprocol + Mitomycin DC8C74C Terameprocol Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Thioguanine + Mitomycin DCTZE9Z Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Thioguanine + Mitomycin DCIZ70H Thioguanine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Thioguanine + Mitomycin DCNC0JK Thioguanine Astrocytoma (Cell Line: U251) [4]
Thioguanine + Mitomycin DCQ6ELF Thioguanine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Thioguanine + Mitomycin DC0BW0W Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [4]
Thioguanine + Mitomycin DC7NTQT Thioguanine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Thioguanine + Mitomycin DC2WZZE Thioguanine Renal cell carcinoma (Cell Line: SN12C) [4]
Thioguanine + Mitomycin DC2V2MG Thioguanine Carcinoma (Cell Line: RXF 393) [5]
Thioguanine + Mitomycin DC45A94 Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [5]
Thioguanine + Mitomycin DCZ99S5 Thioguanine Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Thioguanine + Mitomycin DCFKMIK Thioguanine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Thioguanine + Mitomycin DC7BKIW Thioguanine Adenocarcinoma (Cell Line: SW-620) [6]
Thioguanine + Mitomycin DCGJQGZ Thioguanine Adenocarcinoma (Cell Line: HCT-15) [6]
Thioguanine + Mitomycin DCM4JO9 Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Tivantinib + Mitomycin DC3DKX8 Tivantinib Ewing sarcoma (Cell Line: TC-71) [6]
Topetecan + Mitomycin DCN351T Topetecan Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Topotecan + Mitomycin DCPAHAH Topotecan Carcinoma (Cell Line: RXF 393) [5]
Topotecan + Mitomycin DC79K4M Topotecan Carcinoma (Cell Line: MCF7) [5]
Topotecan + Mitomycin DCSQN9W Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Topotecan + Mitomycin DC1H5OJ Topotecan Amelanotic melanoma (Cell Line: MDA-MB-435) [6]
Topotecan + Mitomycin DCJQCHB Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [6]
Topotecan + Mitomycin DCFQ85Z Topotecan Glioma (Cell Line: SF-268) [6]
Topotecan + Mitomycin DCVA7OL Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Topotecan + Mitomycin DC0AN9H Topotecan Lung adenocarcinoma (Cell Line: EKVX) [6]
Topotecan + Mitomycin DCRXU7P Topotecan Melanoma (Cell Line: MALME-3M) [6]
Topotecan + Mitomycin DCHQ2ZU Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Topotecan + Mitomycin DCGTBLB Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Topotecan + Mitomycin DCS46OW Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [6]
Topotecan + Mitomycin DC1W037 Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Torin2 + Mitomycin DCUYN5J Torin2 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Triapine + Mitomycin DC1ICYR Triapine Adenocarcinoma (Cell Line: HT29) [6]
Triapine + Mitomycin DCVFF1P Triapine Astrocytoma (Cell Line: U251) [6]
Triapine + Mitomycin DC0QHRJ Triapine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [6]
Triapine + Mitomycin DC3IXCW Triapine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [6]
Triapine + Mitomycin DCO46N6 Triapine Lung adenocarcinoma (Cell Line: NCI-H522) [6]
Triapine + Mitomycin DCAPN49 Triapine Melanoma (Cell Line: MALME-3M) [6]
Trifluridine + Mitomycin DCZK81K Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Trifluridine + Mitomycin DC1EBH0 Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [4]
Trifluridine + Mitomycin DCRS6P7 Trifluridine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Trifluridine + Mitomycin DCBZ0F8 Trifluridine Glioma (Cell Line: SF-268) [4]
Trifluridine + Mitomycin DC9QPVJ Trifluridine Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Trifluridine + Mitomycin DC6KEXL Trifluridine Carcinoma (Cell Line: RXF 393) [5]
Trifluridine + Mitomycin DC3SDQU Trifluridine Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Trifluridine + Mitomycin DC34HSL Trifluridine Adenocarcinoma (Cell Line: NCIH23) [6]
Trifluridine + Mitomycin DCZV2AZ Trifluridine Lung adenocarcinoma (Cell Line: EKVX) [6]
Trifluridine + Mitomycin DC96THB Trifluridine Melanoma (Cell Line: MALME-3M) [6]
Trifluridine + Mitomycin DCFV1SP Trifluridine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Trifluridine + Mitomycin DCETKAR Trifluridine Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
Triptolide + Mitomycin DCLQ120 Triptolide Diffuse large B cell lymphoma (Cell Line: TMD8) [6]
Uracil mustard + Mitomycin DC8KSSZ Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [4]
Uracil mustard + Mitomycin DCJNE40 Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [4]
Uracil mustard + Mitomycin DC8HNEY Uracil mustard Astrocytoma (Cell Line: SNB-19) [4]
Uracil mustard + Mitomycin DCYUYKH Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [4]
Uracil mustard + Mitomycin DC1JAME Uracil mustard Glioblastoma (Cell Line: SNB-75) [4]
Uracil mustard + Mitomycin DCMAMZ9 Uracil mustard Glioma (Cell Line: SF-295) [4]
Uracil mustard + Mitomycin DCOZUJY Uracil mustard Glioma (Cell Line: SF-268) [4]
Uracil mustard + Mitomycin DCD0YFY Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Uracil mustard + Mitomycin DCKWADS Uracil mustard Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Uracil mustard + Mitomycin DC4SN0C Uracil mustard Invasive ductal carcinoma (Cell Line: BT-549) [5]
Uracil mustard + Mitomycin DCQKXVO Uracil mustard Adenocarcinoma (Cell Line: SW-620) [6]
Uracil mustard + Mitomycin DCKNJVJ Uracil mustard Adenocarcinoma (Cell Line: HT29) [6]
Uracil mustard + Mitomycin DC4GJRW Uracil mustard Adenocarcinoma (Cell Line: HCT-15) [6]
Uracil mustard + Mitomycin DC6YRI9 Uracil mustard Adenocarcinoma (Cell Line: HCT116) [6]
Uracil mustard + Mitomycin DCTS7RH Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Uracil mustard + Mitomycin DCJCHMD Uracil mustard Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Uracil mustard + Mitomycin DCMS331 Uracil mustard Lung adenocarcinoma (Cell Line: EKVX) [6]
Uracil mustard + Mitomycin DCI34Z6 Uracil mustard Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Valrubicin + Mitomycin DCBRRDQ Valrubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Valrubicin + Mitomycin DC00XFK Valrubicin Glioma (Cell Line: SF-539) [4]
Valrubicin + Mitomycin DCW58RH Valrubicin Adenocarcinoma (Cell Line: HCC-2998) [6]
Valrubicin + Mitomycin DC2N1S7 Valrubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Vandetanib + Mitomycin DC8G0E4 Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Vandetanib + Mitomycin DCKNKR9 Vandetanib Carcinoma (Cell Line: RXF 393) [5]
Vandetanib + Mitomycin DCYXEL5 Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Vandetanib + Mitomycin DCD1CJX Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Vandetanib + Mitomycin DCRQ5T8 Vandetanib Adenocarcinoma (Cell Line: SW-620) [6]
Vandetanib + Mitomycin DCD55RN Vandetanib Anaplastic large cell lymphoma (Cell Line: SR) [6]
Vandetanib + Mitomycin DCOEEYB Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [6]
Vandetanib + Mitomycin DCE2509 Vandetanib Clear cell renal cell carcinoma (Cell Line: TK-10) [6]
Vandetanib + Mitomycin DCEDT9V Vandetanib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [6]
Vandetanib + Mitomycin DC91YM5 Vandetanib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Vandetanib + Mitomycin DC8X83B Vandetanib Lung adenocarcinoma (Cell Line: EKVX) [6]
Vandetanib + Mitomycin DCYFGQI Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [6]
Vandetanib + Mitomycin DCS1OCE Vandetanib Melanoma (Cell Line: MALME-3M) [6]
Vandetanib + Mitomycin DCBI1IW Vandetanib Papillary renal cell carcinoma (Cell Line: ACHN) [6]
Vandetanib + Mitomycin DC8HV0J Vandetanib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Vemurafenib + Mitomycin DCX0QTD Vemurafenib Carcinoma (Cell Line: RXF 393) [5]
Vemurafenib + Mitomycin DCZRVZ3 Vemurafenib Carcinoma (Cell Line: MCF7) [5]
Vemurafenib + Mitomycin DC1L4QK Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Vemurafenib + Mitomycin DCQV4Z3 Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Vemurafenib + Mitomycin DCLQZXG Vemurafenib Adenocarcinoma (Cell Line: DU-145) [6]
Vemurafenib + Mitomycin DCXOTWU Vemurafenib Astrocytoma (Cell Line: SNB-19) [6]
Vemurafenib + Mitomycin DCKKYRH Vemurafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [6]
Vemurafenib + Mitomycin DCGLLZH Vemurafenib Chronic myelogenous leukemia (Cell Line: K-562) [6]
Vemurafenib + Mitomycin DC9T6FL Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [6]
Vemurafenib + Mitomycin DCD245X Vemurafenib Clear cell renal cell carcinoma (Cell Line: A498) [6]
Vemurafenib + Mitomycin DCWQFVC Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [6]
Vemurafenib + Mitomycin DCYAYUU Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Vemurafenib + Mitomycin DC5MOAO Vemurafenib Lung adenocarcinoma (Cell Line: EKVX) [6]
Vemurafenib + Mitomycin DC1J71B Vemurafenib Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Vemurafenib + Mitomycin DC3NV5J Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [6]
Vemurafenib + Mitomycin DCKBZ4P Vemurafenib Malignant melanoma (Cell Line: UACC62) [6]
Vemurafenib + Mitomycin DCOFPPI Vemurafenib Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
Vemurafenib + Mitomycin DCPIXIN Vemurafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Vemurafenib + Mitomycin DCZ1YTR Vemurafenib Plasma cell myeloma (Cell Line: RPMI-8226) [6]
Vemurafenib + Mitomycin DCKZNOH Vemurafenib Prostate carcinoma (Cell Line: PC-3) [6]
Vincristine + Mitomycin DC9GK7C Vincristine Adenocarcinoma (Cell Line: A549) [4]
Vincristine + Mitomycin DCOWIJD Vincristine Adenocarcinoma (Cell Line: HT29) [4]
Vincristine + Mitomycin DCR7QYK Vincristine Adenocarcinoma (Cell Line: HCT-15) [4]
Vincristine + Mitomycin DCBYMPU Vincristine Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Vincristine + Mitomycin DCU4LNB Vincristine Glioma (Cell Line: SF-539) [4]
Vincristine + Mitomycin DCD77GR Vincristine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Vincristine + Mitomycin DCU3B5Z Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vinflunine + Mitomycin DC4PHYL Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [4]
Vinflunine + Mitomycin DCUDAMM Vinflunine Astrocytoma (Cell Line: SNB-19) [4]
Vinflunine + Mitomycin DCFNL5N Vinflunine Glioma (Cell Line: SF-539) [4]
Vinflunine + Mitomycin DC1XVYU Vinflunine Papillary renal cell carcinoma (Cell Line: ACHN) [4]
Vinflunine + Mitomycin DCJ2BLH Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [4]
Vinflunine + Mitomycin DCQKIUZ Vinflunine Renal cell carcinoma (Cell Line: UO-31) [4]
Vinflunine + Mitomycin DCTUJMU Vinflunine Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vinflunine + Mitomycin DCLUW36 Vinflunine Adenocarcinoma (Cell Line: DU-145) [6]
Vinflunine + Mitomycin DCN7FI1 Vinflunine Adenocarcinoma (Cell Line: HCT-15) [6]
Vinflunine + Mitomycin DCO626B Vinflunine Adenocarcinoma (Cell Line: SW-620) [6]
Vinflunine + Mitomycin DCDW2R5 Vinflunine Adenocarcinoma (Cell Line: HT29) [6]
Vinflunine + Mitomycin DC79GOI Vinflunine Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Vinflunine + Mitomycin DC7NFTV Vinflunine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [6]
Vinflunine + Mitomycin DCS1S6X Vinflunine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Vinflunine + Mitomycin DCDOL4N Vinflunine Malignant melanoma (Cell Line: UACC62) [6]
Vismodegib + Mitomycin DCL0F7X Vismodegib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Vismodegib + Mitomycin DCFFB62 Vismodegib Carcinoma (Cell Line: RXF 393) [5]
Vismodegib + Mitomycin DCPT422 Vismodegib Colon carcinoma (Cell Line: KM12) [5]
Vismodegib + Mitomycin DCODQ05 Vismodegib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Vismodegib + Mitomycin DCYKC69 Vismodegib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vismodegib + Mitomycin DCYCD72 Vismodegib Anaplastic large cell lymphoma (Cell Line: SR) [6]
Vismodegib + Mitomycin DC5CJBR Vismodegib Astrocytoma (Cell Line: SNB-19) [6]
Vismodegib + Mitomycin DCRDVK9 Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [6]
Vismodegib + Mitomycin DC8R5CV Vismodegib Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Vismodegib + Mitomycin DCCQUY8 Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Vismodegib + Mitomycin DCJ2LSY Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Vismodegib + Mitomycin DCX0VPT Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [6]
Vismodegib + Mitomycin DC8XBGA Vismodegib Malignant melanoma (Cell Line: UACC62) [6]
Vismodegib + Mitomycin DCVO3HS Vismodegib Plasma cell myeloma (Cell Line: RPMI-8226) [6]
Vismodegib + Mitomycin DCOD9UJ Vismodegib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Vorinostat + Mitomycin DC1VT2H Vorinostat Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
VX-680 + Mitomycin DCF17DR VX-680 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Withaferin A + Mitomycin DC631XG Withaferin A Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
XL880 + Mitomycin DCFXZJP XL880 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Y-700 + Mitomycin DCE1RP7 Y-700 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Ym155 + Mitomycin DC4G0DC Ym155 Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
Zarnestra + Mitomycin DCZDUE6 Zarnestra Diffuse large B cell lymphoma (Cell Line: TMD8) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 1238 DrugCom(s)
2 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Mitomycin + Capecitabine DCC64EG Capecitabine Carcinoma of Anal Canal [7]
Gemcitabine + Mitomycin DCJP1NF Gemcitabine Non-Muscle Invasive Bladder Neoplasms [8]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7089).
2 Mitomycin FDA Label
3 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
4 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
5 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
6 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
7 ClinicalTrials.gov (NCT01843452) Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal
8 ClinicalTrials.gov (NCT06211764) A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Gurin (BCG)